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Inflammatory cytokines induce apoptotic and necrotic cell shedding 2 (PKD2) it remains unclear to what extent genotype correlates with
phenotype. To investigate if groups of PKD2 mutations could be identi-from human proximal tubular epithelial cell monolayers. P.A. Glynne
and T.J. Evans, Department of Infectious Diseases, Division of Investi- fied which differ in their expression of phenotype, survival data were
compared from 24 PKD2 families in which the mutation had beengative Sciences, Imperial College School of Medicine, Hammersmith
Hospital, London, UK. Acute tubular injury in sepsis is associated with identified. From affected family members the age at death or onset of
end-stage renal disease (ESRD) was recorded. Individuals who wereproximal tubular epithelial cell (PTEC) detachment into the lumen
leading to back-leakage of glomerular ultrafiltrate and tubule obstruc- alive and had not reached ESRD were entered as censored data.
Cluster analysis of survival data, employing either a generalised Wil-tion. Inflammatory cytokines, such as IL-1a, IFNg and TNFa, are
important mediators in sepsis-induced acute renal failure, although coxon or Log Rank statistic, was used to identify those protein regions
in which mutations cause significantly poor or good survival. Amongtheir precise role is unclear. We used primary cultures of human PTEC
to investigate the hypothesis that inflammatory cytokines exert cyto- the mutations identified, 22 were nonsense mutations (2 recurrent)
and 2 missense mutations. With respect to survival among the 234toxic effects and cause detachment of cells from adherent monolayers,
possibly through the intermediate nitric oxide (NO). At 5 days post- affected individuals, three significantly different groups of mutation
were identified. Poorest survival occurred in families with mutationsconfluence, PTEC monolayers were stimulated for 24 hours with IL-1a
(10 ng/ml), IFNg (200 u/ml) and TNFa (10 ng/ml). Monolayer viability located in the first large extracellular loop of polycystin-2. The pre-
was assessed by a live/dead dual fluorescence labeling technique. Apo- dicted PKD2 protein, mutations in the N-terminal region and the first
ptosis within monolayers was determined by morphological examina- half of the C-terminus were associated with the longest survival, while
tion and terminal deoxynucleotidyl transferase-mediated dUTP nick- mutations elsewhere were associated with intermediate survival. The
end labeling (TUNEL). PTEC in supernatants were counted and then identification of groups of mutations in the PKD2 gene associated
analyzed by flow cytometry, using propidium iodide to assess cell viabil- with significantly good or bad survival is the first clear evidence of a
ity and annexin V labeling to determine apoptosis. Results (mean 6 genotype/phenotype correlation in PKD2 and adds valuable informa-
SEM; monolayers, n 5 4; cell counts, n 5 3; flow cytometry, n 5 2) tion to our understanding of the function of polycystin-2.
are shown below (at test, p , 0.05).
Macrophages activated in vivo and ex vivo coordinately trigger apopto-
Monolayers Supernatants sis and suppress mitosis of mesangial cells. J.S. Duffield1, L-P. Erwig2,
A. Rees2, and J.S. Savill1, 1Dept. of Medicine, University Hospital, Not-
Viable necrotic apoptotic viable necrotic apoptotic
tingham, UK and 2Institute of Medical Sciences, University of Aberdeen,counts
% of cells 3104/ml % of cells UK. The resident glomerular population is regulated by mitosis and
apoptosis. Unscheduled glomerular cell apoptosis is important in glo-
Unstimulated 99.060.5 1.060.5 0 8.060.6a 64.662.5a 26.761.9a 6.260.6a merular scarring. We sought evidence that apoptosis of cloned and
Stimulated 92.463.2 7.663.2 0 14.760.6a 37.960.05a 48.060.3a 14.160.35a primary cultured rat mesangial cells (RMC) was regulated by rat bone
marrow-derived Mφ (RBMMφ) activated ex vivo, and/or by in vivo-
activated glomerular Mφ isolated from rats with telescoped nephrotoxicFollowing cytokine stimulation, there were significantly increased num- nephritis. Mesangial cells were labelled with CM green tracker dye,bers of shed cells in supernatants. This cell population demonstrated
then plated in a 1:1 ratio with activated Mφ. RMC apoptosis, mitosissignificant loss of viability with increased numbers of both necrotic
and cell number were assessed at 8, 16 and 24 h by propidium iodideand apoptotic cells, as compared to unstimulated PTEC supernatants.
staining of fixed monolayers and blinded, quantitative fluorescenceCytokine-stimulated monolayers maintained viability with no signifi-
microscopy. Neither RBMMφ nor resident Mφ from normal glomerulicant cell necrosis and no evidence of apoptosis. Preliminary experi-
significantly affected RMC mitosis or apoptosis. However, RBMMφments with the NO synthase inhibitor L-NMMA show that it reduces
primed for 18 h with gIFN (100 U/ml) then stimulated with TNFathe number of cytokine-induced shed cells to the levels found in unstim-
(100 U/ml) or LPS (1 mg/ml), or those isolated directly from inflamedulated cells (8.0 6 1.0 3 104/ml), although the percentages of necrotic
glomeruli, induced RMC apoptosis by up to 15 fold over control andand apoptotic cells are unchanged from cytokine-stimulated PTEC
completely blocked RMC mitosis, leading to a reduction in RMC(44% and 15%, respectively). In conclusion, inflammatory cytokines
number at 24 h. Inhibitors of the enzyme NOS2, L-NMMA (100 mM)induce necrotic and apoptotic cell shedding from PTEC monolayers
and L-NIL (30 mM) completely abrogated the Mφ effects on mesangialwith maintenance of monolayer viability. Preliminary data suggest that
cells. D-NMMA (100 mM) was ineffective. The Mφ stimulation condi-NO plays a cytotoxic role in this process.
tions, either ex vivo or in vivo, all promoted nitric oxide (NO) elabora-
tion as assessed by the Griess reaction. gIFN and TNFa in combination
were able to weakly induce NOS2 in RMC (but only 1/1000 the produc-Location of mutations within the PKD2 gene influences clinical out-
tion of NO compared with a Mφ), rendering these cells susceptible tocome. N. Hateboer1, D. Peters2, J. San-Millan3, N. Bogdanova4, M.
Fas mediated death, revealing more than one possible mechanism byBreuning2, E. Coto5, M. v. Dijk2, S. Jeffery6, A. Saggar-Malik6, R. Torra7,
which apoptosis occurs. These data support a new concept; that acti-B. Veldhuisen2, M. Krawczak1, and D. Ravine1, 1Institute of Medical
vated Mφ direct apoptosis in glomerular cells in addition to suppressingGenetics, UHW, Cardiff; 2Anthropogentica, Leiden; 3Genetica Molecu-
mitosis, by at least one mechanism, involving NO. This could havelar, Madrid; 4Humangenetik, Munster; 5Genetico Molecular, Oviedo; 6St.
important implications for the regulation of glomerular cell numberGeorge’s Hospital Medical School, London; 7Hosp. Clinic I Provincial,
Barcelona. For Autosomal Dominant Polycystic Kidney Disease type and the outcome of glomerulonephritis.
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Lipoxins stimulate macrophages to phagocytose apoptotic neutrophils. J.M. Macleod, K.E. White, S.M. Marshall, and R.W. Bilous, Department
of Medicine, University of Newcastle upon Tyne, UK. 50 normotensive,S. Mitchell, K. Harvey, V.V. Fokin1, N.A. Petasis1, C. Godson, and
H.R. Brady. Centre for Molecular Inflammation and Vascular Research, albuminuric patients with insulin dependent diabetes mellitus (IDDM)
have been entered into a multicentre, prospective, longitudinal, double-Department of Medicine and Therapeutics, Mater Misericordiae Hospi-
tal, University College Dublin, Ireland and 1Department of Chemistry, blind study and randomised to receive enalapril, nifedipine retard or
placebo for three years. Renal biopsy is performed at baseline andUniversity of Southern California, Los Angeles, CA, USA. Lipoxins
(LX) are lipoxygenase-derived eicosanoids generated through cell-cell follow-up and morphometric analyses applied. Baseline data is pre-
sented. Mean age was 38.1 (range 20–64) yrs, duration of diabetes 21.9interactions during inflammation and other vascular events. LX are
potent inhibitors of neutrophil (PMN) chemotaxis, PMN-endothelial (4–43) yrs, mean arterial blood pressure 92 6 7 mmHg, median over-
night albumin excretion rate (AER) 102 (26–1589) mg/min and meancell interactions, and PMN recruitment in several model systems, and
are putative endogenous anti-inflammatory compounds that promote iohexol glomerular filtration rate (GFR) 99 (57–162) ml/min/1.73 m2.
resolution of inflammation. Here, we report that LX promote a second Mesangial and matrix volume fractions and glomerular basement mem-
key step in this process, namely phagocytosis of apoptotic PMN by brane (GBM) widths were greater in the IDDM group compared to
monocyte-derived macrophages (Mφ). Human PMN and Mφ were controls (0.44 6 0.1 vs 0.29 6 0.06, P , 0.001; 0.27 6 0.07 vs 0.16 6
isolated by standard procedures. Apoptosis of aged PMN was con- 0.03, P , 0.001 and 577 6 129 vs 363 6 53 nm, P , 0.001). All were
firmed by dual laser flow cytometry and light and electron microscopy. related to AER (r 5 0.56, P , 0.001; r 5 0.56, P , 0.001 and r 5
Phagocytosis of apoptotic PMN by Mφ was assessed by a myeloperoxi- 0.52, P , 0.001) but not to GFR. 25 patients had significant numbers
dase-based light microscopy assay (expressed as % of total Mφ con- of sclerosed glomeruli (.10%). In this group the mean GFR was lower
taining apoptotic PMN) and confirmed by electron microscopy. Treat- compared to patients with less than 10% sclerosed glomeruli (92 6
ment of Mφ with LXA4 stimulated phagocytosis of apoptotic PMN 11 vs 106 6 3 ml/min/1.73 m2, p 5 0.05). Thus despite normal blood
(mean 6 SEM: vehicle 7.3 6 1.7%, LXA4 16.0 6 2.5%, n 5 3) in a pressure, normal serum creatinine and for the majority, normal GFR,
dose dependent manner (EC50 1 3 1029 M). This bioactivity was also IDDM patients with albuminuria have advanced glomerulopathy with
observed with LXB4, the other major LX generated by mammalian basement membrane thickening, mesangial expansion and significant
cells, and by the LX stable analogues 15R/S-methyl-LXA4 and 16- numbers of sclerosed glomeruli.
phenoxy-LXA4. Pretreatment of the Mφ with a neutralizing antibody to
CD36 inhibited LX-stimulated phagocytosis. Mφ express high affinity
receptors for LXA4. The stimulatory effects of LX on Mφ phagocytosis N-Acetylcysteine improves renal function in the hepatorenal syn-
were blunted by prior exposure of Mφ to pertussis toxin and to 8-Br drome. Steve Holt, R. Marley, B. Fernando, D. Goodier, D. Patch, and
cAMP, suggesting that receptor-mediated changes in intracellular Kevin Moore, The Centre for Nephrology, The Royal Free Hospital,
cAMP may be an important modulator of this process. Studies are Pond St., London NW3 2QG, UK. The development of the hepatorenal
ongoing to further characterize the intracellular signals and the adhe- syndrome has a poor prognosis with a .90% mortality rate. The cause
sion ligands that subserve this process. In aggregate, these data expand of renal failure in this syndrome is unknown, but is thought to involve
the spectrum of potential anti-inflammatory activities of LX and sup- hemodynamic changes together with increased synthesis of vasoactive
port a role for these eicosanoids as braking signals for PMN-mediated mediators. Spontaneous resolution of this syndrome is rare, and usually
tissue injury in human disease. dependent upon hepatic recovery. Recent evidence suggesting that
oxidative stress may be involved in the pathogenesis of the hepatorenal
syndrome led us to conduct a pilot study to investigate the possible
Placebo-controlled trial of intravenous immunoglobulin in ANCA- renoprotective effects of the anti-oxidant N-Acetylcysteine (NAC) in
associated systemic vasculitis. D. Jayne, H. Chapel1, J. Adu2, D. O’Do- HRS. In this pilot study NAC was administered for 5 days to 12 patients
noghue3, S. Misbah4, D. Scott5, and C.M. Lockwood6, Renal Unit, St. with the HRS. This treatment was given to patients with declining
Helier Hospital, Surrey; 1Dept. Immunology, John Radcliffe Hospital, renal function where no further therapy was available. All patients
Oxford; 2Dept. Nephrology, Queen Elizabeth II Hospital, Birmingham; had a rising serum creatinine, which had been unresponsive to volume
3Dept. Nephrology, Hope Hospital, Salford; 4Dept. Immunology, Gen- challenge with colloid and all had been treated with low dose dopamine
eral Infirmary, Leeds; 5Dept. Rheumatology, Norfolk and Norwich Hos- and intravenous antibiotics. Renal function improved in 10 out of 12
pital, 6Dept. Medicine, Clinical School, Cambridge. Intravenous, patients, as assessed by a decrease in serum creatine and an increase
pooled, normal human immunoglobulin (IVIg) is a potential alterna- in creatinine clearance. Prior to therapy the slope of the increasing
tive treatment for ANCA-associated systemic vasculitis (AASV) with serum creatinine was 115 mmol/day while the slope of days 1 to 5 was
less toxicity than conventional immunosuppressive agents. A ranom-
28 mmol/day (P , 0.01). Creatinine clearance improved from a meanised, placebo-controlled trial was conducted to demonstrate the efficacy baseline value of 26 6 4 ml/min at day 0 to 45 6 4 ml/min at day 5of a single course of IVIg (total dose 2 g/kg) on vasculitis activity, in (P , 0.002). The one month survival rate in this group was 67%,previously treated AASV with persistent disease activity in whom
although one of the 12 patients received a liver transplant followingthere was an intention to escalate therapy. Vasculitic activity was moni-
completion of this study. These results suggest that NAC may be atored by the Birmingham vasculitis activity score (BVAS), C-reactive
useful adjunctive therapy in the treatment of HRS which may at leastprotein (CRP), and anti-neutrophil cytoplasm antibody (ANCA) levels
represent bridging therapy, giving further opportunity to improve he-and a treatment response defined as a reduction in BVAS of more
patic dysfunction or arrange for liver transplantation.than 50% after three months. There was an intention to keep doses
of concurrent immunosuppression unchanged for three months; open
follow-up continued to 12 months. Seventeen patients were randomised
Renal cancers and malformations in relatives of patients with Bardet-to receive IVIg and 17 to receive placebo. Treatment responses were
Biedl syndrome. P.L. Beales1, A.S. Woolf 2, H.A.S. Reid3, M.H. Grif-found in 14/17 and 6.17 of the IVIg and placebo groups respectively
fiths4, and F.A. Flinter1, 1Division of Molecular and Medical Genetics,(P 5 0.015). Following infusion of trial medication greater falls in CRP
Guy’s Hospital, London SE1 9RT, UK; 2Nephrourology Unit, Institutewere seen at two weeks (P 5 0.01) and one month (P 5 0.04) in the
of Child Health, London WC1 1EH, UK; 3Department of Histopathol-IVIg group. No differences between the two groups were observed
ogy, Chase Farm Hospital, Middlesex EN2 8JL, UK; 4Department offor ANCA levels or cumulative exposure to immunosuppressive drugs,
Histopathology, University College London Medical School, Londonor for disease activity, CRP or relapse rates after three months. Eigh-
WC1E 6JJ, UK. Bardet-Biedl syndrome (BBS) is an autosomal reces-teen adverse-effects occurred after IVIg and six after placebo; they
sive disorder with four loci identified thus far. The spectrum of diseasewere mostly mild although reversible rises in serum creatinine occurred
includes diverse malformations of the kidney and lower urinary tract.in five receiving IVIg. A single source of IVIg reduced disease activity
The incidence of BBS is approximately 1/100,000 with a predictedin persistent AASV but this effect was not maintained beyond three
heterozygote frequency of 1/160, and it has been suggested that hetero-months, reversible side-effects following IVIg were frequent.
zygotes are at increased risk of obesity and hypertension. In this study
we sought renal disease in relatives of 110 UK BBS patients and genetic
evidence to implicate BBS loci in the pathogenesis of these disorders.Albuminuria, even in the absence of hypertension, indicates established
glomerulopathy in insulin dependent diabetic patients. L.A. Baines, Clear cell renal adenocarcinoma was diagnosed in 3/180 BBS parents
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and there was loss of heterozygosity at both BBS1 (11q13) and BBS4 whether MG at pathophysiologically relevant concentrations, contrib-
(15q23) loci in the tumour tissue of two of these subjects. In addition, utes to increased AGE-type fluorescence. HSA (5 mg/ml) was incu-
there was a high incidence of renal agenesis in siblings of BBS patients, bated at 378C for 30 days in 100 mM phosphate/0.01% sodium azide
two BBS families were identified with apparently dominant inheritance buffer, pH 7.4, containing either 0.1 mM, 2.0 mM or 1.0 mM MG or
of renal malformations. In one family we were able to demonstrate 100 mM glucose. The control comprised HSA incubated in phosphate
that renal malformations segregated with the BBS2 locus (16q21). buffer. Incubation solutions were replenished with MG every two or
Since all parents and 2/3 siblings of BBS patients must be heterozygous three days to mimic in vivo conditions. HSA-linked AGE formation
for BBS mutations, our observations implicate BBS genes in the patho- was assessed at 1, 2, 5, 10, 20 and 30 days by measurement of fluores-
genesis of both renal cancer and malformations, both disorders of cence (Ex350, Em430). Qualitative comparisons of AGE products were
precursor cell growth and differentiation. We suggest these observa- made by fluorescence emission (Ex350, Em370–500) and excitation (Ex260– 400,
tions may have important implications for screening potential BBS Em430) scans. Incubation of HSA with MG showed a time and concen-
carriers for kidney disease and may lead to a greater understanding tration dependent increase in AGE formation. AGE generation with
of the aetiology of renal disease in the general population. all concentrations of MG was greater (P , 0.05) than HSA incubated
in buffer alone (by 3% for 0.1 mM, 11% for 2 mM and 15-fold for 1
mM at 30 days). AGE generation with 1 mM MG was 6-fold greater
Individual kidney function is not dictated by the presence of stenosis than with 100 mM glucose (P , 0.05). Fluorescence emission and
in atherosclerotic nephropathy. C.K.T. Farmer, J. Reidy1, G. Cook2, excitation spectra for HSA incubated with MG were broad and had
and J.E. Scoble, Departments of Nephrology, Radiology1 and Nuclear2 similar maxima to that of HSA incubated in glucose. We conclude
Medicine, Guy’s Hospital, St Thomas’ Street, London. Angioplasty is that pathophysiologically relevant concentrations of MG react with
often performed to improve renal function in atherosclerotic nephropa- proteins to form fluorescent AGEs with similar characteristics to those
thy on the basis that renal ischemia is causing a decline in renal function. arising from incubation of proteins with glucose and that it may contrib-
Renal angioplasty is not always associated with an improvement renal ute to the increase in AGEs in uraemia and diabetes and in patients
function. Recently we have shown that single kidney GFR does not treated by conventional PD.
improve following renal angioplasty. Using a novel technique of syn-
chronous 99mTc-DMSA and 51Cr-EDTA to provide a measure of single
kidney GFR (SKGFR) we prospectively examined the correlation Haemodialysis serum inhibits endothelial cell (EC) expression of tissue
between SKGFR and presence of stenosis in atherosclerotic nephropa- factor (TF). P. Maderna, P. Coleman, C. Godson, Y.M. O’Meara, and
thy. We studied 48 patients with angiographically proven renovascular H.R. Brady, Centre for Molecular Inflammation and Vascular Research,
disease and included those patients with unilateral renal artery stenosis Dept. of Medicine and Therapeutics, Mater Misericordiae Hospital,
(n 5 30) or unilateral renal artery occlusion (n 5 18), with contra- University College Dublin, Ireland. Disorders of coagulation are com-
lateral normal of stenosed renal artery. The mean age was 70 (59–87), mon among HD patients. The mechanisms by which HD perturbs the
male:female ratio 30:29. The mean SKGFR in the kidneys with a coagulation cascade are still being defined. Here, we report that serum
stenosed renal artery was 17.32 ml/min compared to those with a from patients undergoing dialysis inhibits EC expression of TF, a
normal renal artery 13.6 ml/min. procoagulant membrane-associated protein that serves as a receptor
and cofactor for factor VIIa. Serum was collected from stable ESRD
patients during maintenance dialysis and assessed for its ability to
influence TF activity in ECV304, a spontaneously transformed human
EC line. TF activity was measured by a one stage clotting time assay
on cell lysates. Serum was sampled immediately pre-dialysis and from
the venous blood line after 15, 30 and 180 minutes of conventional
heparin/bicarbonate HD using polysulphone hollow fibre dialyzers
(Fresenius AG, Germany). Pre-dialysis uraemic serum did not influ-
ence EC levels of TF. HD was associated with the appearance of a
serum factor that suppressed basal TF levels (TF units/mg protein: pre-
dialysis 8.2 6 0.9; 180 mins dialysis 4.9 6 0.6; P , 0.05) and TF
expression induced by the cytokine TNF-a (TF units/mg protein: TNF-a
alone 15.9 6 0.7; TNF-a 1 180 mins dialysis serum 5.9 6 0.9; P , 0.01).
This response was not mimicked by heparin, suggesting production of
an endogenous inhibitor of TF activity. In keeping with this hypothesis,
These results imply that renal ischaemia was not the only process HD was associates with time-dependent increase in circulating levels
causing a decline in renal function in atherosclerotic nephropathy. of tissue factor pathway inhibitor (TFPI), a physiological inhibitor ofGiven that these patients act as their own controls we conclude that the TF/VIIa complex, possibly released by activated platelets. Suppres-presence of stenosis in atherosclerotic nephropathy does not predict
sion of endothelial cell TF expression may contribute to haemorrhagicrenal function in that kidney. However the presence of an occluded
complications in HD patients.renal artery was associated with severe renal dysfunction, mean GFR
2.6 ml/min. Angioplasty may be a useful treatment if the aim is to
prevent renal artery occlusion but not if it is to improve renal function.
The effect of membrane biocompatibility on serum leptin levels in
haemodialysis patients. M.J. Wright, G. Woodrow, S. Kendall, G.
Young, A. Brownjohn, and J.H. Turney, Renal Unit, Leeds General
Infirmary, Great George St., Leeds. Biocompatible dialysis membranesIn vitro advanced glycation end product formation with methylgly-
(BCM) may lead to less malnutrition than bio-incompatible mem-oxal—a glucose breakdown product in uraemic and diabetic sera and
branes (BICM). Leptin regulates nutrient intake in rats and is presentperitoneal dialysis fluid. D.J. Millar, P.J. Thornalley1, and A. Dawnay,
in supra-normal concentrations in dialysis patients. Leptin synthesisDepartment of Clinical Biochemistry, The Medical School at St. Bartho-
may be increased by cytokines such as Il-1 and TNF, therefore increasedlomew’s Hospital, London, UK and Department of Biological and
levels of leptin in the bio-incompatible group may contribute to aChemical Sciences1, University of Essex, Colchester, UK. Accelerated
poorer nutrient intake. We designed a randomised prospective cross-advanced glycation end product (AGE) formation due to carbonyl
over study to assess leptin levels in patients dialysing on a BICMstress may occur in uraemia, diabetes and as a result of PD treatment.
(Gambro GFE; cuprophane) and a BCM (Asahi Biowet; polyethyleneOne candidate compound, the oxoaldehyde methylglyoxal (MG), is
glycol grafted cellulose. 32 patients (10 F, 22 M: mean age 61 years)elevated in uraemia (up to 1 mM), diabetes (up to 2 mM) and is present
completed the study. Half of the group were randomised to eachin PD fluid (up to 12 mM) as a consequence of heat sterilization causing
membrane. They dialysed for two months after which a morning pre-glucose degradation, a process known to accelerate AGE formation.
We have used a model protein, human serum albumin (HSA), to test dialysis leptin sample was taken. C reactive protein and Kt/Vurea were
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also measured. Each patient then changed to the other membrane and 3London School of Hygiene and Tropical Medicine, London, UK. The
NTDS is a prospective cohort study of clinical outcomes, quality of lifethe process was repeated.
and costs of dialysis in a large sample of patients aged over 70 years.
This paper explores the effect of dialysis adequacy on clinical outcomes.
Two groups were followed-up for one year: incident patients (IP), newBICM BCM P
to dialysis, who entered the study 3 months after starting, (50 M, 20 F;
Mean leptin ng/ml /kg 0.4660.11 0.68 60.23 ,0.05 40 HD, 30 PD) and prevalent patients (PP), who had been on dialysis
Mean CRP mg/dl 0.8561.9 2.01 65.4 ,0.05 for 5 mos–10 years when the study started (56 M, 33 F; 52 HD, 37 PD).
Kt/V 1.1460.04 1.16 60.03 NS From the mean of 3 measures of adequacy taken at 6 month intervals
during the year patients were categorised as adequately or inadequately
dialysed. Adequate treatment was defined as: Kt/V . 1.2 or URR .
65% (HD 3 3/wk); Kt/V . 1.8 or URR . 80% (HD 3 2/wk); weeklyThe results show a significantly lower leptin and CRP in the BICM
Kt/V . 1.9 (CAPD). 79% of HD patients were dialysed 33/wk. 14group, although there was not correlation between leptin and CRP
(20%) incident and 21 (24%) prevalent patients died. Cox regression(r 5 20.12 for BCM; r 5 20.17 for BICM). Female leptin levels were
analyses, controlling for age, sex, modality, comorbid conditions, latesignificantly higher than male (mean 1.74 ng/ml/kg vs 0.2 ng/ml/kg for
referral to a nephrologist (,1 month before starting dialysis) and timeBCM and 1.06 ng/ml/kg vs 0.18 ng/ml/kg for BICM: P , 0.01 for both).
on dialysis (PP only), showed that adequate dialysis did not predictLeptin levels correlated with weight for men and there was a trend
1-year survival in either group (IP: P 5 .56; PP: P 5 .93). On standardtoward significance for females. Our results suggest that the leptin
multiple regression analyses, controlling for the same confoundingconcentration may be affected by the dialysis membrane. Further inves-
factors, annual hospitalisation rate (excluding admissions for accesstigation is required to clarify whether there is increased synthesis or
problems) was significantly predicted by treatment adequacy only inreduced clearance by this BCM. Further work is required to determine
IP: adequate dialysis was associated with .88 fewer admission/p-yr asthe relevance of leptin to appetite control in dialysis patients.
compared to inadequate treatment (P 5 .048). However the effect of
adequacy on morbidity was not confirmed in PP (P 5 .92). Adequacy
of dialysis is not a predictor of short-term survival in elderly patients.QT dispersion and mortality in haemodialysis patients. H. Gallagher,
In new patients dialysis good adequacy appears to reduce annual hospi-P.A. Andrews, J.T.C. Kwan, and N. Velasco, SW Thames Renal Unit,
talisation rates. There was no effect in elderly patients who had beenSt. Helier Hospital, Carshalton, Surrey, UK. Cardiovascular disease
on chronic dialysis for more than 5 months. A cohort study withis the commonest cause of death in patients on haemodialysis. The
extended follow-up is needed to investigate the long-term effects ofidentification of markers to predict cardiovascular death would facili-
adequate dialysis in the elderly.tate the stratification of risk in this high risk population, and also the
rational allocation of scarce resources such as transplantation. Left
ventricular hypertrophy is a risk factor for mortality, both in the general
Chloramine induced haemolysis presenting as erythropoietin resis-population and in dialysis patients. Similarly, QT dispersion has been
tance. S. Fluck, W. McKane, T. Cairns, V. Fairchild, A. Lawrence,found to predict sudden death in patients with acute myocardial in-
J. Lee, D. Murray1, M. Polypitiye, A. Palmer, and D. Taube, Brentfarction, chronic heart failure, diabetes, and peripheral vascular disease.
Laboratory, St. Mary’s Hospital, London and Renal Unit1, Lister Hospi-We retrospectively studied mortality in haemodialysis patients in rela-
tal, Stevenage. In December 1996 [figure 1] we identified an outbreaktion to left ventricular hypertrophy (LVH) and QT dispersion. 36 cases
of erythropoietin resistance [r-HuEPO R] requiring a substantial in-(deaths in patients on haemodialysis) were studied, with age and sex
crease in r-HuEPO dosage in one [the Mint Wing] of our 4 haemodial-matched living haemodialysis patients as controls. ECGs were analysed
ysis [HD] units. Conventional causes of r-HuEPO R were considered.with a digitiser and the presence of LVH documented. QT intervals
Iron, B12 and folate deficiency, inadequate dialysis, significant hyper-were recorded, both to the apex and to the end of the T wave, and
parathyroidism, sepsis, and activation of underlying disease were ex-the QTa and QTe dispersions were calculated as QTmax-QTmin. The
cluded. Routine [6 monthly] water analysis had shown that nitrate,values were also rate-corrected using Bazett’s formula. Results were
copper, aluminium, bacterial counts and endotoxin levels had remainedexpressed as mean 6 SE. Analysis was by Mann Whitney U test. The
within accepted AAMI standards. However, in the Mint Wing, weanalysis was repeated excluding cases and controls with LVH.
noted that the dialysate chloramine levels had risen from ,0.1 ppm
in October 1996 to 0.3 ppm in April 1997 and 0.25 ppm in October
1997 whereas in our other 3 HD units levels were persistently ,0.1Cases (n536) Controls (n536) P value
ppm. A subgroup of 15 patients were examined for evidence of haemol-
QT maximum ms 436.5610.0 426.267.7 NS ysis during HD [methaemoglobin and haptoglobin levels, reticulocyte
QTa dispersion ms 55.563.0 42.962.5 0.003 counts and Heinz body formation]. There was a mean increase in
QTe dispersion ms 76.265.5 60.964.2 0.014 methaemoglobinaemia of 23% [P , 0.01] and a 21% fall in haptoglo-
QTca dispersion ms 65.563.9 48.862.9 0.004 bins [P , 0.01] across HD, although no patient had a reticulocytosis
QTce dispersion ms 89.265.3 69.164.6 0.005 and only one patient with G6PD deficiency had Heinz bodies. Larger
carbon filters were installed in the Mint Wing in December 1997. ThereLVH excluded Cases (n516) Controls (n524) P value
was an 18.6% rise [P , 0.001] in mean haemoglobin levels within one
QT maximum ms 423.9616.8 417.768.5 NS month and a subsequent 25.0% reduction [P , 0.001] in mean r-HuEPO
QTa dispersion ms 52.864.7 41.563.2 NS dose. Intradialytic changes in methaemoglobin and haptoglobin were
QTe dispersion ms 74.566.6 53.764.3 0.009 abolished. Mint Wing dialysate chloramine levels fell to ,0.1 ppm.
QTca dispersion ms 63.867.1 46.463.6 NS Data subsequently extracted from Thames Water revealed a sustained
QTce dispersion ms 89.667.1 59.964.8 0.003 two-fold increase in mains water total chlorine levels [predominantly
chloramine] dating from November 1996.
These results suggest that QT dispersion may be a marker for mortality
Impact of end-stage renal disease (ESRD) on employment and per-in haemodialysis patients, and that this effect may also be relevant in
sonal economics: identification of musculoskeletal dysfunction as a riskthe absence of ECG evidence of LVH. Prospective studies are required
factor for unemployment. C. Blake, A. Cassidy, M. Codd, J. Donohoe,for further evaluation.
F. Walker, A. Watson, J.A.B. Keogh, H.R. Brady, and Y.M. O’Meara,
Department of Medicine and Therapeutics, Mater Misericordiae Hospi-
tal, University College Dublin, Ireland. The psychosocial impact ofEffect of dialysis adequacy on morbidity and mortality in elderly dial-
ESRD is still being appreciated. Here, we evaluated the influence ofysis patients. S.A.C. Harris1, N. Constantinovici2, E.A. Brown1, and
ESRD on the employment status, employment potential and personalD.L. Lamping3, for the North Thames Dialysis Study (NTDS) Group,
1Charing Cross Hospital, 2Royal Free Hospital School of Medicine, economics of 200 patients using an investigator administered question-
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diastolic and systolic [Ca21]i values were not different, contraction
amplitude was significantly reduced in U cells by 25% (7.8 6 0.6%,
C vs 5.9 6 0.7, U; P , 0.05). In summary, we have found impaired
contractile function and altered [Ca21]i handling in uraemic cardiac
myocytes stimulated at a normal rat heart rate. These data provide
some evidence of altered excitation-contraction coupling in experimen-
tal uraemia.
The effect of uraemic compounds on expression of osteoblast PTH/
PTHrP receptor mRNA in vitro. M.L. Picton1, A.J. Hutchison1, R.
Gokal1, and J.A. Hoyland2, Renal Research Group1, Manchester Royal
Infirmary, Manchester and Musculoskeletal Research Group2, Univer-
sity of Manchester, UK. Down-regulation of osteoblast PTH/PTHrP
receptors has been implicated in the resistance of PTH in renal failure.
Previous work using in situ hybridisation has shown significant down-
regulation of PTH/PTHrP receptor mRNA in human bone in renal
failure. This study aimed to examine the effect of ‘uraemic toxins’ on
osteoblast PTH/PTHrP receptor mRNA expression in vitro, using in
situ hybridisation. SaOS-2 cells were cultured in the presence of 1%
or 10% FCS. At confluence medium containing either 1% or 10%naire that incorporated components of the Labour Force and House-
FCS with Urea 200, 100 and 50 mmol/litre, Creatinine 2000, 1000 andhold Budget Survey and the SF-36 Health Survey. This cohort included
500 micromol/litre, Methylguanidine 100, 50 and 25 micromol/litre,93 hemodialysis (HD), 42 peritoneal dialysis (PD) and 65 transplant
Spermine 1, 0.5 and 0.25 micromol/litre or Spermidine 4, 2 and 1(TX) patients. Of patients aged 18–65, 57 (40%) were in paid employ-
micromol/litre was introduced. After 12 and 24 hours exposure thement, 55 (38%) reported being unable to work or retired as a conse-
cells were washed and fixed and in situ hybridisation carried out usingquence of ESRD, and 29 (20%) were students or homemakers. Em-
a 39S labelled cDNA PTH/PTHrP receptor probe, followed by autoradi-ployed patients lost an average of 33 working days per year due to
ography and quantification of signal. At 12 hours significant increasesESRD related illness. Among unemployed patients, 18 (33%) reported
in PTH/PTHrP mRNA expression occurred for all compounds excepta desire to regain employment, whereas 37 (67%) perceived themselves
spermine in the presence of 10% FCS which was associated with aas unable to work due to permanent illness or disability. Upon assess-
reduction in receptor mRNA expression. At 24 hours in the presencement of quality of life (SF-36), employment was associated with signifi-
of 1% FCS urea and methylguanidine at the concentrations testedcantly higher scores for general health (P , 0.01), physical function
significantly increased receptor mRNA, spermine and spermidine were(P , 0.002) role physical (P , 0.0001), role emotional (P , 0.01), bodily
associated with much less impressive increases. When cells were cul-pain (P , 0.03) and vitality (P , 0.01). Unemployment was significantly
tured in medium containing 10% FCS for 24 hours methylguanidine,higher among dialysis patients when compared to transplantation (P ,
spermine and spermidine were associated with significant increases in0.05). Factors that could compromise employment potential were ex-
receptor mRNA expression, whilst there was a return to control levelsamined. Interestingly, disabling musculoskeletal dysfunction was re-
for creatinine and urea. All results were analyzed using ANOVA,ported by 61% of ESRD patients and was associated with significant
significance at P , 0.05. This work suggests some uraemic compoundscompromise of physical employment capacity. Indeed, patients with
may influence expression of osteoblast PTH/PTHrP receptor mRNA.musculoskeletal disease had lower quality of life indices for all physical
It is also apparent that in vitro culture conditions such as FCS concen-health domains than patients without musculoskeletal disease (P ,
0.01). In contrast, neither dialysis modality nor proximity to a dialysis tration and duration of test exposure are important considerations.
Currently Northern blot studies are underway examining PTH/PTHrPcenter impacted upon this parameter. Further dissection of the factors
that limit employment should identify remedial factors that will return mRNA expression by osteoblasts cultured under identical conditions
as described above, allowing more definitive conclusions to be made.ESRD patients to the workforce and improve their quality of life.
Intracellular Ca21 and contraction in uraemic cardiac myocytes: effect Modulation of Hyaluronan During the in vitro Repair of Human
Peritoneal Mesothelial Cells (HPMC). Sue Yung and Malcolm Davies,of stimulation rate. A.C. McMahon, A.M. Mullen, M.J. Hurst, and M.M.
Yaqoob, Anthony Raine Research Labs, St. Bartholomew’s Hospital, Institute of Nephrology, UWCM, Royal Infirmary, Cardiff. Hyaluronan
(HA) has been implicated in tissue repair but its role during injury toLondon. We have previously reported both contractile dysfunction
and disordered intracellular Ca21 ([Ca21]i) handling in single cardiac the peritoneum is poorly understood. To delineate a possible role of
the linear polysaccharide we have investigated several aspects of HAmyocytes from uraemic animals exposed to raised extracellular Ca21.
In the current study we examined [Ca21]i and contractile function metabolism using an in vitro model of peritoneal wound repair. Con-
fluent, growth arrested HPMC were mechanically wounded and thein paced ventricular myocytes from uraemic and control animals at
different stimulation rates. Male Wistar rats were rendered uraemic synthesis of HA during the repair process was determined by the
incorporation of [3H]-glucosmaine into radiolabelled-HA. De novo(U, n 5 7) by 5/6 nephrectomy, and sham-operated control animals
were also prepared (C, n 5 8). Eight weeks later (prior to sacrifice) synthesis was maximal 24 h after injury (4.2 6 0.15 fold; n 5 3) com-
pared to controls. No difference was observed in the hydrodynamicblood pressures were measured using a tail-cuff method in conscious
animals. Cardiac myocytes were isolated and loaded with the fluores- size of the [3H]-HA synthesized by the wounded and control cells.
Cytochemical staining for UDP glucose dehydrogenase, an enzymecent Ca21 indicator Indo-1. Cells were placed in a superfusion chamber
on the stage of an inverted microscope, with field stimulation set at which converts UDP-glucose to UDP-glucuronate, a precursor of HA
was localised to the cells at the margin of the wound and also to those60, 120 and 300 beats per min (bpm) in turn. Transient changes in
[Ca21]i and the corresponding contraction amplitude (% change in cells migrating into the wound. This staining was confirmed using a
biotinylated binding protein to localise HA. Control and woundedcell length) were simultaneously measured at each stimulation rate.
Multiple cells were studied from each heart (C, n 5 24; U, n 5 14). cells were also probed for CD44, a receptor for HA. Fluorescent
immunolocalisation showed that prior to wounding, CD44 was locatedMeasurements are expressed as mean 6 SEM. Blood pressures and
body weights were similar in each group, although there was a signifi- around the periphery of all cells. In comparison, in the injured mono-
layer immuno-staining of CD44 was absent from the cells entering thecant increase in serum creatinine (65 6 3 mmol/l, C vs 120 6 6, U; P ,
0.0001). At low stimulation rates (60–120 bpm), [Ca21]i handling and wound, but still present on those cells at the margin and away from the
wound. Using RT-PCR we next investigated the mRNA for hyaluronancontractile function were similar in the two groups of cells. At 300
bpm however the U cells displayed a faster time to peak [Ca21]i than synthase (HAS II and HAS III). Prior to wounding only mRNA for
HAS III was detected. After injury to the monolayer mRNA for HASC (49 6 2 ms, C vs 39 6 1, U; P , 0.00001). In addition, although
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II was induced at 12 h and remained elevated for up to 72 h. In contrast Modulation of mesangial cell MAP kinase activities by leukotrien D4
and lipoxin A4. B. McMahon, F. McPhillips, A. Fanning, H.R. Brady,mRNA for HAS III was reduced during the same time period. These
findings suggest that HAS II and HAS III are differentially regulated and C. Godson, Centre for Molecular Imflammation and Vascular Re-
search, Dept. of Medicine and Therapeutics, Mater Misericordiae Hospi-in response to mesothelial damage. In a separate study wounded cells
were co-cultured with endotoxin-free HA (Mr 250,000 kDa). The inclu- tal, University College Dublin, Ireland. Lipoxygenase-derived eicosanoids
are potent modulators of glomerular inflammatory injury. Leukotrienesion of HA (range 0–3.3 mg/ml) increased the rate of cell migration
in a dose dependent manner. This response to HA was abrogated by D4 (LTD4), a well-defined proinflammatory mediator, induces intrare-
nal vasoconstriction, mesangial cell contraction and hyperahesivenessprior digestion of the HA to disaccharides with Streptomyces hyaluroni-
dase. These findings suggest that HA plays a critical role in the response of endothelial and mesangial cells for phagocytic leukocytes. Lipoxins
(LX) are putative endogenous anti-inflammatory eicosanoids and an-of the mesothelium to injury.
tagonize these LTD4-triggered responses. Both LTD4 and LXA4 elicit
their bioactions through G-protein coupled receptors (GPCR). How-
ever, the signalling pathways activated down-stream to GTP hydralysisFlow induces dilatation in the femoral artery of uraemic rats but con-
striction in control rats. T. Savage1, R.M. Tribe, and M.M. Yaqoob, remain relatively undefined. The MAP kinase superfamily (erk, p38
and JNK) plays a pivotal role in connecting GPCR activation to criticalAnthony Raine Research Labs, St. Bartholomew’s Hospital, 1Dept. Fetal
Health Research, St. Thomas’ Hospital, London. Flow is acknowledged intracellular responses. Here we have determined the effect of LXA4
and LTD4 on activation of erk, p38 and JNK kinases in a transformedas an important factor in endothelium-dependent vascular tone. The
effect of uraemia on flow-induced dilatation remains unknown. Six human mesangial cell line. Lysates were prepared from cells treated
with either LXA4, LTD4 or both agents. Kinase activation was deter-pairs of male Wistar rats were rendered uraemic (U) by 5/6th nephrec-
tomy or concurrently sham operated as controls (C). After 8 weeks, mined using phosphoprotein specific antibodies in immunoblotting
experiments and by measuring phosphorylation of specific substrates.the rats were sacrificed and blood sent for U&Es. Isolated femoral
arteries were mounted on a flow myograph, pressurised at 80 mmHg Our data demonstrate that LXA4 and LTD4 activate p38 kinase, JNK
and erk albeit with different kinetics and dose dependence. LXA4in physiological salt solution (PSS) and constricted by 40–50% of the
lumen internal diameter (i.d.) by extraluminal application of l-phenyl- pretreatment of mesangial cells attenuates LTD4 activation of p38.
LTD4 activation of p38 is partially sensitive to pertussis toxin (PTX)ephrine. Flow using PSS was initiated (28–207 ml/min) in 6 steps every
5 minutes and changes in i.d. recorded. L-NAME (10-4) and the novel whereas the effect of LXA4 on p38 activation is PTX insensitive. These
data are critical to our understanding of the putative counter-regulatorycGMP inhibitor ODQ (10-6) were applied extraluminally, and the flow
protocol repeated. Serum urea and creatinine were significantly higher role of LXA4 in LTD4 mediated glomerular injury.
in the Us vs Cs (urea 12 6 0.9 mmol/L vs 6 6 0.2 mmol/L P , 0.001,
creatinine 97 6 4 mmol/L vs 77 6 2 mmol/L, P , 0.01) and the baseline
i.d., at 80 mmHg was smaller (255 6 21 mm vs 365 6 36 mm P , 0.03) Expression of Angiopoietin-1, Angiopoietin-2 and the Tie-2 receptor
tyrosine kinase during mouse kidney maturation. Hai-Tao Yuan, Chitrarespectively. At all steps, flow elicited a dilatation in the U group and
a constriction in the C group (U 124 6 8% vs C 217 6 5% P , Suri*, George D. Yancopoulos*, and Adrian S. Woolf, Nephrourology
Unit, Institute of Child Health, University College London Medical0.01). When L-NAME and ODQ was added to the perfusion bath, a
significant basal reduction in i.d. at 80 mmHg was observed in the C School, London WC1N 1EH, UK and *Regeneron Pharmaceuticals
Inc., Tarrytown, NY 10591, USA. The Tie-2 receptor tyrosine kinasegroup but not in the U group (C 233 6 7% vs U 23 6 7% P , 0.05).
Furthermore, in response to flow in uraemic vessels, no significant transduces endothelial maturational and morphogenetic signals, with
Angiopoietin-1 (Ang-1) acting as a stimulatory ligand and Ang-2 postu-blunting to the dilatation was observed (Us mean 19 6 4%, P 5
ns). To conclude, paradoxically, flow elicited a constriction in control lated to be a naturally occurring inhibitor. We sought expression of
these genes during mouse kidney maturation from the onset of glomer-vessels but a marked dilatation in mildly uraemic vessels which was
not nitric oxide dependent. Therefore other mediators such as prosta- ulogenesis (embryonic day 14; E14) to the end of nephron formation
(two weeks postnatal), and during medullary maturation into adult-cyclin or endothelium-dependent hyperpolarizing factor (EDHF) may
contribute to flow-induced dilatation in mild uraemia. hood. Using Northern blotting (Ang-1, Ang-2 and Tie-2) and Western
blotting (Tie-2) of the lysates of whole organs, we found these genes
were expressed throughout the experimental period with peak levels
Scavengers of reactive oxygen species and L-arginine protect kidney at two and three weeks postnatal. Maximal Tie-2 tyrosine phosphoryla-
from oxidised low density lipoprotein (ox-LDL) induced vasoconstric- tion, a surrogate marker of in vivo bioactivity, occurred between late
tion. M.M. Rahman, Z. Varghese, and J.F. Moorhead, Renal Research gestation and three weeks postnatal. At the latter time point, using in
Unit, Royal Free Hospital, London, UK. We have shown that ox-LDL situ hybridisation and immunohistochemistry, Tie-2 localised to vasa
induces vasoconstriction in isolated perfused rat kidney (IPRK) in a rectae endothelia and to the core of immature glomeruli. As assessed
dose dependent manner in contrast to native LDL and this vasocon- by in situ hybridisation, Ang-1 was expressed in glomerular podocytes
striction is mediated by decreased activity of nitric oxide (NO). We while an intense signal for Ang-2 was detected in pericytes/interstitial
therefore investigated whether it can be reversed by L-arginine and cells adjacent to capillaries in maturing vasa rectae. In addition, iso-
the role of reactive oxygen species in this vasoconstrictory process. lated, Tie-2 protein expressing cells were detected in medullary stroma
Ox-LDL (50 mg/ml) induced vasoconstriction i.e. reduction in renal of the E15 metanephros and we speculate that these were endothelial
perfusate flow (RPF) was compared in the absence and presence of precursors. Based on these data, we hypothesise that Tie-2 has roles
L-arginine (100 & 500 mM), D-arginine (100 & 500 mM), superoxide in differentiation of vasa rectae and glomeruli.
dismutase (SDO, 150 U/ml), catalase (1200 U/ml) & both SOD 1
catalase (n 5 6 in each series). The presence of L-arginine significantly
decreased ox-LDL induced vasoconstriction. RPF was increased from Protein kinase C-dependent stereospecific regulation of endothelial
cell tissue factor gene expression by lipoxins. P. Maderna, P. Chanya-69.8 6 3.6% of base line with ox-LDL alone to 84.5 6 4.3% and 94.3 6
5.6% in the presence of 100 & 500 mM L-arginine respectively (P , puthipong1, N.A. Petasis, C. Godson, and H.R. Brady, Centre for Molec-
ular Inflammation and Vascular Research, Dept. of Medicine and Thera-0.05). D-arginine did not have any significant effect. SOD & catalase
both separately had significant inhibitory effect and SOD 1 catalase peutics, Mater Misericordiae Hospital, Univ. Coll. Dublin, Ireland, and
1Dept. Chemistry, Univ. Southern California, Los Angeles, CA, USA.almost completely abolished the vasoconstriction. RPF was raised to
78.4 6 3.6% of base line by the presence of SOD, 86.5 6 4.3% by the Lipoxins (lipoxygenase interaction products) are eicosanoids generated
via transcellular biosynthetic pathways during platelet-neutrophil inter-presence of catalase and to 98.4 6 5.1% of base line by the presence
of SOD & catalase together from 68.8 6 4.0% by ox-LDL alone (P , actions within the vascular lumen in human diseases. These novel lipid
mediators modulate leukocyte-endothelial cell interactions and vascu-0.05). We conclude that ox-LDL induced vasoconstriction in IPRK
mediated by decreased activity of NO may be due to inactivation of lar tone in several model systems. Their influence on the coagulation
cascade has not been determined. Here, we report that LXA4 potentlyNO by reactive oxygen species and L-arginine has protective role.
L-arginine has also been shown to have free radical scavenging property (threshold 1029 M) stimulates endothelial cell tissue factor (TF) activ-
ity. TF activity was measured in lysates from a spontaneously trans-besides serving as a substrate for NO synthesis.
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formed human endothelial cell line (ECV304) using a one stage clotting bated PMN showed a significant decrease in CD16 binding and a
assay. This bioactivity was stereospecific for LXA4 and was not ob- significant increase in annexin V binding with positive PI staining
served with LXB4, the other major lipoxin generated by mammalian compared with normal IgG at 18 and 24 hours. Fluorescence micros-
cells. Furthermore, induction of TF expression was not observed with copy showed an increase in apoptotic and necrotic PMN when incu-
16-phenoxyl-LXA4, a stable analogue of LXA4, or 15(R/S)-methyl- bated with ANCA at similar time-points. There was loss of the tight
LXA4, a racemic mixture that covers the biological activities of aspirin- correlation between CD16 binding and annexin V binding, with re-
triggered 15-epi-LXA4. This structure/function profile differs markedly duced CD16 binding in primed PMN incubated with ANCA suggesting
from those observed for other LX-triggered responses. Our initial additional activation of PMN. Primed PMN incubated with ANCA
assessment of the cell signaling events that transduce this response secreted more IL-8 compared with normal IgG. Results of TNF-a
shows that the effect of LXA4 is receptor-triggered, G-protein-coupled primed PMN (2 3 106/ml) cultured for 18 hours (mean 6 SD, n 5 6),
and protein kinase C dependent. LXA4-induced TF activity was com- IL-8 data at 6 hours (mean 6 SD, n 5 6) are shown below (aP , 0.05).
pletely inhibited by cycloheximide and was associated with increased
TF mRNA levels, as determined by northern analysis. The protease
inhibitors TLCK and TPCK which inhibit nuclear translocation of
CD16 Annexin V Annexin V 1 Normalc-Rel/p65 prevented LXA4 induction of TF expression, suggesting a binding binding PI staining cells by IL-8cytokine-like regulation of TF gene expression. These results indicate
% total % total % total microscopy Productionthat LXA4 may be an important modulator of EC thrombogenicity. cells cells cells % total cells pg/mlThe recognition that lipoxygenase-derived eicosanoids modulate EC
gene expression greatly expands the potential pathophysiological roles No IgG 43.87613.6 49.7568.39 21.5068.75 41.966.6 434641.6
of these lipid mediators. Normal IgG 55.70615.7 41.61614.42 14.0768.2 52.03614.7 414659.8
Anti-MPO IgG 10.89612.7a 70.23619.4a 38.0169.06a 27.62615.1a 1051.76153a
Anti-PR3 IgG 7.76614.8a 66.4617.5a 27.32612.9a 38.1267.9a 606661.8*
Inflammatory cytokines and adhesion molecules in human renal dyspla-
sia. C.M. Cale, N.J. Klein*, and A.S. Woolf, Nephrourology and Immu-
nobiology* Units, Institute of Child Health, UCLMS, 30 Guilford Street, In conclusion, ANCA appears to induce apoptosis and necrosis in
London WC1N 1EH, UK. We previously demonstrated that the in- TNF-a primed PMN though not quiescent PMN. This accelerated
flammatory cytokine, tumour necrosis factor (TNF)-a is present in apoptosis is preceded by neutrophil activation.
mouse metanephroi and that increased concentrations inhibit renal
development and increase macrophage numbers in organ culture. The
phenotype seen with TNF-a resembles that of the congenital renal Recombinant interleukin-11 is effective in ameliorating glomerulone-anomaly renal dysplasia (Cale et al Int J Dev Biol 1998 42:663–674). phritis in Wistar-Kyoto rats. P.C Lai, H.T. Cook, F.W.K. Tam, J. Smith,The expression and distribution of macrophages and adhesion mole- and C.D. Pusey, Depts. of Medicine and Histopathology, Hammersmithcules are altered by TNF-a in adult tissues. We hypothesised that i)
Campus, Imperial College School of Medicine, London, UK. IL-11 isTNF-a is present in normal human embryonic kidneys, and increased
an anti-inflammatory cytokine that can reduce the production of pro-in renal dysplasia and ii) macrophage distribution is altered in renal
inflammatory cytokines such as TNF-a and IL-1b. It has been reporteddysplasia and iii) the expression of adhesion molecules in renal dyspla-
that the anti-inflammatory activity of IL-11 is mediated in part bysia is abnormal. In the present study we demonstrated expression of
inhibition of NF-kB-dependent transcriptional activation. We there-TNF receptors 1 and 2 in the developing metanephros and their down-
fore studied the effect of recombinant IL-11 in preventing glomerularregulation in postnatal life. Messenger RNA but not TNF-a protein
injury in a model of crescentic glomerulonephritis in WKY rats. Glo-was demonstrated in the normally developing human metanephros.
merulonephritis was induced by giving rabbit anti-rat GBM antiserumHowever, cells expressing TNF-a protein and persistent expression of
(NTS) intravenously. IL-11 (106 U/100 g/day) was given subcutaneouslyTNF receptor 2 was noted in fetal dysplastic tissue. In addition, TNF-a
2 hours before NTS and then once daily until rats were killed on day 6.was detected in the urine of fetuses with obstructed urinary tracts and
Glomerular fibrinoid necrosis and apoptosis were assessed in H&Eassociated renal dysplasia. We also demonstrated that neural cell and
sections. Immunohistochemistry was performed for macrophagesintercellular adhesion molecules (NCAM and ICAM) were expressed
(ED-1), proliferating cell nuclear antigen (PCNA), inducible nitricand macrophages were present in early human renal development.
oxide synthase (iNOS) and CD8 cells (OX-8). Urine protein was as-In both fetal and post-natal dysplastic tissues there was abnormal
sessed by the sulphosalicylic acid method. Results (mean 6 SEM) areexpression of NCAM around dysplastic tubules and ICAM within
shown below. (*P , 0.05)dysplastic tubules. In addition, macrophages were abnormally distrib-
uted within the interstitium in dysplastic tissues. We suggest that abnor-
mal expression of adhesion molecules may inhibit tubular differentiation
and thus contribute to the pathogenesis of renal dysplasia. Inflamma- IL-11 (n510) Control (n58)
tory cells may also contribute to this process and both these effects
Proteinuria mg/24h 1363* 63 64may be secondary to increased levels of TNF-a in dysplastic kidneys.
Fibrinoid quadrants/glom 0.5860.08* 1.52 60.06
Macrophages/glom 2462* 39 62
PCNA1 cells/glom 2462* 37 62Anti-neutrophil cytoplasmic antibodies (ANCA) induce neutrophil
iNOS1 cells/glom 3.160.3* 2.0 60.1apoptosis in primed neutrophils in vitro. L. Harper, C.J. Brooks, D.
CD81 cells/glom 1.660.3 1.7 60.3Adu, and C.O. S. Savage, Centre for Clinical Research for Immunology
Apoptotic cells/100 gloms 5.2 60.6 6.5 61.0Signalling, The Medical School, University of Birmingham, Bir-
mingham. The aim of this study was to assess whether ANCA would
influence neutrophil (PMN) survival by affecting apoptosis in vitro.
IL-11 treatment reduced glomerular injury as shown by significantlyQuiescent PMN or PMN primed with TNF-a (80 iu/ml) were incubated
decreased fibrinoid necrosis and proteinuria. Macrophage infiltrationwith no IgG, 200 mg/ml of normal IgG or ANCA (either anti-MPO
and PCNA 1ve cells were also significantly reduced. INOS 1ve cellsor anti-PR3 IgG) for up to 36 hours. Apoptosis was assessed by FACS
were significantly increased in IL-11 treated rats. Numbers of CD81analysis of PMN binding FITC-conjugated anti-CD16 IgG or FITC-
or apoptotic cells were not different. Thus, in this model of crescenticconjugated annexin V. Cell viability was assessed by propidium iodide
glomerulonephritis, early treatment with IL-11 can decrease glomerular(PI) staining. Cell morphology was viewed by fluorescence microscopy
inflammation and injury, in part by reducing macrophage infiltration.of ethidium bromide and acridine orange stained PMN. PMN apoptosis
Cell proliferation is reduced. Interestingly, this is associated with anwas confirmed by DNA gel electrophoresis. In unprimed cells there
increase in INOS expression. Further investigation is necessary to clarifywas no difference in the rate of apoptosis with normal IgG or ANCA.
the precise mechanisms of IL-11 in preventing glomerulonephritis andAs expected, TNF treated cells showed increased apoptosis at 6 hours
but prolonged cell survival at 18 hours. In primed cells, ANCA incu- in particular its effect on other markers of macrophage activation.
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C1q deficient mice have delayed resolution of inflammation in heterolo- Fca receptor and not the prototype Fca receptor, CD89. J. Barratt,
M.R. Greer, A.C. Allen, E.M. Bailey, K.S. Buck, and J. Feehally, Dept.gous nephrotoxic nephritis. M.G. Robson1, H.T. Cook2, M. Botto1,
C.D. Pusey3, M.J. Walport1, and K.A. Davies1, Rheumatology Section1, of Nephrology, Leicester General Hospital, Leicester, UK. The mecha-
nism by which mesangial IgA deposition leads to glomerular injury inDepartment of Histopathology2, and Renal Section3, Imperial College
School of Medicine, Hammersmith Hospital, Du Cane Road, London. IgA nephropathy (IgAN) is poorly understood. Mesangial cells are
believed to play a pivotal role in this process as they bind IgA in vitroComplement activation is thought to play an important role in anti-
body-mediated inflammation. Passive heterologous nephrotic nephritis and this binding stimulates pro-inflammatory cytokine production and
superoxide generation. It has been proposed that mesangial IgA bind-is a model of acute antibody mediated inflammation caused by a single
injection of nephrotoxic IgG. We studied the role of complement ing occurs through the well characterised myeloid Fca receptor (FcaR),
CD89. However the evidence for this is only circumstantial. Here wein this model. C1q deficient mice were generated by gene targeting.
Nephrotoxic IgG was prepared by immunising rabbits with a mouse present data showing that cultured human mesangial cells (HMC)
constitutively express an FcaR, but this is not CD89. Primary HMCglomerular preparation and ammonium sulphate precipitation of the
serum. Wildtype (WT) and C1q deficient (C1qa2/2) mice on a mixed cultures were established from the normal poles of 5 kidneys removed
for carcinoma. Binding of human IgA-FITC was analysed by flowgenetic background (C57BL/6 3 129/SV) were given a single intrave-
nous injection of 5 mg of nephrotoxic IgG. Immunofluorescence cytometry, and specificity of binding determined in competitive inhibi-
tion experiments. Cell surface and cytoplasmic expression of CD89showed linear binding of rabbit IgG on the glomerular basement mem-
brane. C1q, C3 and C4 also bound in a linear pattern in WT mice. were assessed using a panel of five CD89-specific monoclonal antibod-
ies. Parallel experiments were carried out with quiescent and activatedNeutrophils per glomerular cross-section were counted at various times
after injection of nephrotoxic IgG with 10–15 mice of each genotype HMC. Expression of CD89 mRNA was then assessed by RT-PCR in
each of the five HMC lines. All five HMC cultures showed Fc-depen-per time-point. At 2 hours there were significantly more neutrophils
per glomerular cross-section in the C1qa2/2 group (median 4.28) dent IgA binding which was dose-dependent, saturable and upregu-
lated on cell activation. At no time could we detect either cell surfacecompared to wildtype (median 3.0, P 5 0.0028, U 5 40). At 10 hours
the difference was not significant (median for C1qa2/2 and WT mice or cytoplasmic expression of CD89. Furthermore, RT-PCR failed to
demonstrate full length CD89 mRNA. However, a truncated sequence0.62 and 0.68 respectively, P 5 0.3529, U 5 40). At 24 hours there
were again more neutrophils in the C1qa2/2 mice (median 0.55) with partial homology to CD89 was detected, suggesting HMC expres-
sion of either a previously undescribed CD89 splice variant or a novelcompared to WT (median 0.12, P 5 0.0004, U 5 30). These results
shows that the absence of C1q causes an increased initial influx of FcaR. Our findings confirm that cultured HMC constitutively express
an FcaR, but this is not CD89. This novel mesangial cell FcaR requiresneutrophils. The increased number of neutrophils in C1qa2/2 mice
at 24 hours was even more striking, demonstrating a delayed resolution detailed characterisation in order to establish its role in the pathogene-
sis of IgAN.of inflammation. We are investigating the mechanisms behind these
observations.
Genome-wide mapping of the loci contributing to mortality in a rat
model of malignant hypertension. S. Kantachuvesiri1, C. Haley2, S.Polarized expression and function of inducible nitric oxide synthase
within the apical membranes of immunostimulated human proximal Fleming3, K. Kurian3, P. Wenham4, Y. Kotelevtsev1, and J. Mullins1,
Centre for Genome Research1, Dept. of Pathology3, Dept. of Clinicaltubular epithelial cells. P.A. Glynne and T.J. Evans, Department of
Infectious Diseases, Division of Investigative Sciences, Imperial College Biochemistry4, University of Edinburgh, and Roslin Institute2, Edin-
burgh, UK. Genetic factors play an important role in disease suscepti-School of Medicine, Hammersmith Hospital, London, UK. The proxi-
mal tubule is the predominant site of injury in sepsis-induced acute bility including cardiovascular and kidney disease. We have previously
described a genetic model of malignant hypertension (MH) in rats linerenal failure (ARF). Recent work has highlighted the importance of
nitric oxide (NO) in this condition, although its precise role is unclear. 27 carrying Ren2, a mouse renin transgene in which the penetrance
of the phenotype is determined by the genetic background (KidneyWe used primary cultures of human proximal tubular epithelial cells
(PTEC) to examine the hypothesis that the inducible isoform of NO Int 47:529–535, 1995). The highest penetrance of MH (100%) was
observed in F1 progeny of male homozygous Ren2 transgenic ratsynthase (iNOS) displays a specific sub-cellular distribution. This would
have important implications for NO modulation of polarized tubular (TGRmRen2-27) and Fischer (F344) females whereas the lowest pene-
trance (58.5%) was found in F1 progeny of TGRmRen2-27 and Lewisfunctions such as ion transport. We investigated (1) NO production
from PTEC stimulated for 24 hours with IL-1a (10 ng/ml), IFNg (200 females. To identify genetic loci contributing to MH and lethality.
We performed a genetic cross between a single male homozygousu/ml) and TNFa (10 ng/ml), measured as nitrate/nitrite (NOx) in PTEC
supernatants, (2) iNOS expression and sub-cellular localization by TGRmRen2-27 and female F344/Lewis F1, rats. A total of 252 male
progeny were phenotyped for clinical and pathological features of MH,immunofluorescence (IF) and confocal microscopy, using an anti-
human iNOS antibody and (3) the functional effects of INOS associated and genome-wide screening was carried out using 125 microsatellite
markers and fluorescent dUTP genotyping. Two loci have been identi-with its structural distribution within the polarized monolayer, by mea-
suring apical and basal NO output from PTEC grown on porous mem- fied which contribute to the MH phenotype. The first locus, with a
LOD score of 4.4, was identified on chromosome 10, in close proximitybrane inserts, using the oxyhaemoglobin method. NOx output from
cytokine-stimulated PTEC was significantly higher than unstimulated to, or coincident with, the Ace locus. The second locus, with a LOD
score of 3.9, mapped to chromosome 17 at, or close to, the At1 locus.cells (128.14 6 13.26 vs. 19.75 6 10.26 nmol/million cells/24 hours,
respectively; P , 0.02). iNOS expression was demonstrated in cytokine- These loci was found to contribute synergistically to the mortality from
MH and their action was independent of blood pressure. The possiblestimulated PTEC only. IF showed a striking apical distribution of iNOS
with sub-cellular localization to the apical cell membranes on serial 0.5 association of ACE and MH was further examined and we found
higher plasma ACE activity in F344 progeny than in Lewis progenymm transverse PTEC sections. iNOS IF displayed a marked punctate
pattern, suggesting colocalization to specific membrane domains such which may contribute to the MH phenotype.
as caveolae. Specificity was confirmed by absorption of staining by the
specific peptide. Apical NO output was significantly higher than basal
Suppressors of cytokine signaling (SOCS): expression by mesangial(3.15 6 0.56 uM vs. 0.91 6 0.1 uM at 24 hours, respectively; P , 0.01).
cells and regulation by cytokines and growth factors. A. McGinty, C.M.These studies are the first demonstration of polarized iNOS expression
King, R. Starr1, D.J. Hilton1, and H.R. Brady, Centre for Molecularwithin the apical membranes of immunostimulated human PTEC and
Inflammation & Vascular Research, Dept. Medicine & Therapeutics,its associated vectorial NO production. We suggest that the compart-
Mater Misericordiae Hospital, University College Dublin, Ireland andmentalization of iNOS within PTEC may have important implications
1Cancer Research Institute, Walter & Eliza Hall Institute, Royal Mel-for NO modulation of specific apical membrane functions such as ion
bourne Hospital, Victoria, Australia. SOCS are a recently identifiedtransport.
family of proteins involved in the negative regulation of cytokine-
triggered JAK/STAT signaling pathways [1]. In this study we assessed
the expression of SOCS-1, -2, -3 and a SOCS superfamily memberIgA binding to human mesangial cells is mediated through a novel
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CIS, in SV-40 transformed murine mesangial cells (MES 13) under X-linked recessive nephrolithiasis (XRN) caused by mutations of the
voltage-gated chloride channel gene CLCN5. The prevalence of tubu-basal conditions and following activation by cytokines and growth
lar proteinuria in patients with CLCN5 mutations compared to thosefactors implicated in the pathogenesis of glomerular disease. SOCS-3
with the overlapping syndromes of distal renal tubular acidosisand CIS, but not SOCS-1 or -2, were constitutively expressed as deter-
(dRTA), idiopathic hypercalciuria (IH) and also patients with glomeru-mined by RT-PCR. Enhancement of SOCS-3 and CIS levels was ob-
lonephritis, in whom low molecular weight (LMW) proteinuria is com-served following activation of MES 13 with the classic pro-inflamma-
mon, is unknown. The LMW proteins retinol-binding protein (RBP)tory cytokines IL-1b, TNF-a and INF-g. SOCS-1 and SOCS-2 were
(see Table), b-2 microglobulin, a1-microglobulin and albumin werenot detected. CIS and SOCS-3 were induced by interleukin-6, a potent
measured in random urine specimens from these patients and patientsmitogen in mesangioproliferative disease. This bioactivity was also
with Chinese Herbs Nephropathy (CHN), a complex tubulopathy withnoted with other IL-6 family members OSM, LIF, CNTF and IL-11.
elevated urinary RBP and albumin, of quite different aetiology toThere is an expanding body of evidence to suggest that the Th2-
CLCN5 mutation.derived cytokines IL-4 and IL-13 promote resolution of glomerular
inflammation. Interestingly, both these mediators induced MES 13
expression of CIS, whereas SOCS-3 was upregulated by IL-4 alone.
Affected CarrierSOCS-1 and SOCS-2 levels were unaffected. Stimulus-dependent regu-
RBP male femalelation of SOCS expression was observed with growth factors which
mg/mmol Dents/ Dents/ IH Normalregulate mesangial cell growth and matrix production. Specifically,
creatinine XRN XRN dRTA Adults GN 16–68 yr.TGF-b and EGF induced CIS, whereas PDGF was without effect.
SOCS-3, by contrast, was induced by EGF but not PDGF or TGF-b. Median 17.8 0.30 0.027 0.0081 0.077 0.0079
These results indicate that MES-13 exhibit differential SOCS expres- (10th–90th)
sion under basal conditions and upon stimulation by cytokines and centile (7.8–4.2) (0.13–3.1) (0.005–0.1) (0.004–0.017) (0.009–3.0) (0.004–0.011)
growth factors. The data suggest that SOCS/CIS may be important n 31 24 16 79 39 61
modulators of mesangial cell activation during glomerular inflamma-
tion. [1] Starr et al (1997) Nature 387:917–921.
RBP was the optimal LMW protein to distinguish female CLCN5
carriers from normal (21/24 above normal reference limit) but RBP
Hyperdynamic circulation and elevated plasma levels of soluble excretion by female carriers overlapped that of patients with dRTA,
p-selectin precede the development of peripheral vasoconstriction and IH and GN, as did RBP excretion by affected males and GN patients.
However, the combination of RBP and albumin uniquely identifiedhypertension in women destined to develop pre-eclampsia. P.M. Bosio,
the proteinuria of 52/55 patients with CLCN5 mutations. There wasS. Cannon, C. Godson, P.J. McKenna1, C. O’Herlihy1, R. Conroy1, H.
a striking correlation between RBP and albumin excretion in femaleMcCann, D. Sugrue, and H.R. Brady, Department of Medicine and
CLCN5 carriers, R 5 0.933 after logarithmic transformation, suggestingTherapeutics, Mater Misericordiae Hospital, University College Dublin,
shared tubular transport mechanisms. An RBP level above the upperand Rotunda Hospital, Dublin, Ireland. The cardiovascular events that
adult reference range (0.017) and albumin level ,(10 3 RBP) 1 2culminate in the clinical syndrome of pre-eclampsia (PE) are still being
identified all patients with the LMW proteinuria of CLCN5 mutations;appreciated. In this study, combined Doppler echocardiography was
this is therefore a possible quantitative definition of tubular proteinuria.used to serially monitor cardiac output and peripheral resistance from
Using this definition, most patients (21/26) with CHN had, as expected,10–14 weeks gestation thru six weeks postpartum in 400 healthy primi-
tubular proteinuria.gravidae. Plasma levels of soluble P-selectin were measured in parallel
as a marker of platelet-endothelial dysfunction. 44 subjects developed
hypertension: 20 pre-eclampsia and 24 gestational hypertension. By Prolongation of porcine islet xenograft survival by non-cytotoxic anti-
comparison with normotensive subjects, patients subsequently devel- MHC class II antibodies. R.M. Smith, M. Koulmanda, and T.E. Mandel,
oping preeclampsia were characterised by elevated cardiac output Academic Renal Unit, Sothmead Hospital, Bristol, and Walter and Eliza
(mean 8.13 L/min, P , 0.001) and comparable peripheral resistance Hall Institute, Melbourne, Australia. Transplantation of pancreatic en-
throughout the preclinical phase. A striking fall in cardiac output (mean docrine tissue offers the prospect of a cure for diabetes. However both
5.56 L/min) and increment in peripheral resistance (mean 1688 dyne/ allogeneic whole pancreas and purified pancreatic islet transplantation
sec/cm2) was observed during the clinical phase of pre-eclampsia. In are severely restricted by organ availability. Xenotransplantation is
one possible solution to this problem. Transplantation of solid organcontrast, all patients who developed gestational hypertension had ele-
xenografts (eg kidney or whole pancreas) remains problematic withvated cardiac output before (mean 8.53 L/min) and after (mean 8.99 L/
the hurdle of hyperacute xenograft rejection still incompletely resolved.min) diagnosis (P , 0.001) and significantly lower peripheral resistance
In contrast islet grafts derive their vasculature from the recipient andtowards term (mean 923 dynes/sec/cm2, P , 0.001). Intriguingly, plasma
are thus not a target for antibody mediated hyperacute rejection. Inlevels of soluble P-selectin were elevated at the end of the first trimester
keeping with this conventional T cell targeted immunosuppressivein subjects who would subsequently develop pre-eclampsia, but not in
therapies are effective in preventing islet xenograft rejection in murinesubjects who would develop gestational hypertension. In aggregate,
and primate models. We have studied the efficacy of a non-cytotoxicthese observations suggest that the pre-clinical phase of pre-eclampsia anti-MHC class II antibody (OX6) in delaying porcine islet xenograftis characterised by hyperdynamic circulation and platelet-endothelial rejection in NOD mice. In this model the grafted tissue is devoid of
cell dysfunction. The elucidation of the molecular events that underpin antigen presenting cells and rejection is therefore dependent on indirect
these early vascular events should shed new light on the pathophysiol- T cell mediated mechanisms of graft rejection. Furthermore, the donor
ogy of this common clinical syndrome. MHC molecules are not recognised by the antibody used and indirect
recognition of graft antigens alone is therefore targeted by the immuno-
therapeutic regimen. Cultured fetal porcine grafts were placed under
Low molecular weight (‘tubular’) proteinuria in patients with mutations the kidney capsule of NOD mice. One mg of OX6 was given ip the
of the CLCN5 renal chloride channel gene. A.G.W. Norden1, J. Asplin2, day before, day of and day after grafting. Grafts were scored according
M.M. Deschodt-Lanckman3, C.B. Langman4, M. Lapsley1, J.L. Nortier3, to an accepted scheme at days 7, 14 and 21 after grafting. Data is
representative of two similar experiments.S.J. Scheinman5, R.V. Thakker6, R.J. Unwin7, and O. Wrong7, 1Dept. of
Chemical Pathology; Chase Farm Hospital, The Ridgeway, Enfield EN2
8JL, Middlesex, England, 2Section of Nephrology, University of Chi-
cago, IL, USA., 3Laboratoire Pluridisciplinaire de Recherche Experim-
entale Biomedicale, Brussels, Belgium, 4Dept. Paediatrics, Northwestern Number of grafts survivingUniv. Med. School, Chicago, IL, USA, 5Department of Medicine, SUNY
Health Science Centre, Syracuse, NY, 6MRC Molecular Medicine, Treatment Day 7 Day 12 Day 21
RPGMS, London, 7Centre for Nephrology, UCLMS, London. Identifi-
OX6 5/5 6/8 1/7cation of tubular proteinuria appears the most consistent screening
PBS 3/5 0/8 1/6test for the X-linked renal syndromes including Dent’s Disease and
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At day seven control grafts showed an eosinophil infiltrate with graft on haemodialysis (pre-dialysis serum creatinine 737–1412 mM). Results
are shown as median (range).necrosis. OX6 treated grafts showed eosinophilic infiltrates but no
necrosis. At day 14 both control and OX6 treated grafts showed heavy
infiltrates but only OX6 treated grafts showed intact endocrine tissue.
By day 21 OX6 treated and control grafts showed heavy infiltrates Control Moderate Haemodialysis
with loss of endocrine tissue. This work demonstrates the unique poten-
gly I 289 (227–394) 327 (288–364) 351 (310–348)tial for the use immunomodulatory agents targeting indirect antigen
nmol /mg hb *P,0.02
recognition for prevention of rejection of xenogeneic islets. gly II 71 (47–88) 86 (76–98) 95 (77–109)
nmol /mg hb *P,0.005 *P,0.0005
D-lactate 16 (12–44) 21 (12–49) 90 (38–183)
lM blood *P,0.02 *&**P,0.0001Human neutrophil defensins have chemoattractant activity for mono-
GSH 0.96 (0.75–1.48) 0.86 (0.73–1.21) 0.70 (0.50–0.94)nuclear cells (MNC) but not neutrophils (PMN): possible role in cell
mM blood *P,0.001, **P,0.01recruitment into the peritoneal cavity. Kieron L. Donovan, Suzanne
glyoxal 0.30 (0.18–0.56) 0.65 (0.20–3.56) 1.33 (0.31–3.77)Jones, John D. Williams, Tomasz Ganz*, and Nicholas Topley, Institute
lM serum *P50.005 *P,0.0005, **P50.06of Nephrology, Royal Infirmary, Cardiff and *Will Rogers Pulmonary
methylglyoxal 0.15 (0.11–0.19) 0.22 (0.13–0.28) 0.62 (0.11–1.00)Research Laboratory, UCLA, CA. Leukocyte migration into the perito-
lM serum *P,0.01 *P,0.005, **P,0.005neal cavity during bacterial peritonitis is characterised by early PMN
*P value vs. controls, ** vs. moderate (Mann Whitney)recruitment and a later mononuclear cell influx. Whilst leukocyte re-
cruitment is known to be primarily controlled by directionally secreted
chemotactic cytokines, little is known about how the switch from in
Gly I and II activities and the concentration of methylglyoxal, glyoxalleukocyte phenotype recruitment is controlled. Previous studies have and D-lactate progressively increased with declining renal function
suggested that PMN-derived small molecular weight cationic peptides suggesting that the reduction in GSH was not rate limiting. The reasons
called defensins (HNP) have chemotactic activity for MNC. In the for the elevation of methylglyoxal and glyoxal are not known but the
present study we have examined the hypothesis that PMN-derived four-fold increase in their concentrations may contribute substantially
HNP might participate in MNC recruitment into the peritoneal cavity to increased de novo AGE formation in uraemia with consequent
during peritonitis. Effluent obtained from 8 patients at onset of perito- detrimental effects on the vasculature.
nitis contained significant levels of HNP (measured by ELISA). Values
ranged from 18–300 ng/ml (median value 122 ng/ml). Non-infected
Pathophysiology of hyperkalaemia in elderly patients. M. Clarkson,effluent did not contain detectable levels of HNP. Using an in vitro
S. Cannon, C. Godson, D. Jones1, J. Horan1, E. Mulkerrin1, and H.R.migration system consisting of a cell free porous (0.3 m pore size) tissue
Brady, Dept. of Medicine and Therapeutics, Mater Misericordiae Hospi-culture insert (coated with type IV collagen) in which the stimulus
tal, University College Dublin, and 1Dept. of Medicine for the Elderly,was added to one side of the membrane we observed that increasing
University College Hospital Galway. Elderly people are prone to thedoses of HNP induced MNC migration. Doses between 3 and 30 ng
development of hyperkalaemia. The defect in kaliuresis in this popula-increased MNC migration [(342 6 153, 421 6 108 and 251 6 130 (3103
tion has not been characterized. Sustained hyperkalaemia usually indi-MNC)] for 3 ng, 30 ng HNP and control respectively (n 5 5, P , 0.05
cates a defect in renal potassium (K1) excretion and can be due tovs control) at higher doses there was a gradual reduction in MNC impairment of glomerular filtration and/or impairment of tubule K1
migration to control levels. These levels represented 30.03% and secretion. The transtubular potassium gradient (TTKG) provides an
66.36% of the levels of migration induced by optimal doses of MCP-1 index of tubule K1 secretion and tubule sensitivity to aldosterone
(30 ng/ml). In contrast, irrespective of dose, HNP did not result in the (Kamel et al, Am J Kid Dis., 1994; 24:597–613). In healthy subjects,
migration of PMN across the membrane although in parallel experi- TTKG rises following administration of an k1 load or following admin-
ments IL-8 (100 ng/ml) resulted in a 15 fold increase in PMN migration. istration of fludrocortisone, an aldosterone analogue. TTKG was as-
In the same migration system pooled infected PDE (from 8 patients) sessed at baseline and repeated 3 hours following oral ingestion of 0.5
induced a dose-dependent migration of MNC across the membrane, mg of fludrocortisone in three groups: elderly patients (n 5 6, mean age
76 years) with unexplained hyperkalaemia (HK), elderly normokalaemicat the optimal dilution (1:5) this was 2 fold greater than that induced
controls (n 5 8, mean age 79 years) (EC), and young (n 5 9, meanby MCP-1 alone. In the presence of saturating concentrations of mono-
age 31 years) control subjects (YC). GFR was assessed or calculatedclonal anti-MCP-1 antibody or anti-HNP antiserum MNC migration
in all patients at baseline. TTKG values were inappropriately low inwas reduced by 86 6 25% and 36.31 6 12% respectively. These data
HK suggesting impaired K1 secretion in the distal cortical nephron.suggest that in addition to classical chemokine control of leukocyte
Following administration of fludrocortisone, TTKG rose significantly inrecruitment during peritonitis that defensins derived from activated
YC (from 7.5 6 0.09 to 11.6 6 1.1, P , 0.05) but not in the HK orPMN might contribute to the control of the phenotype of infiltrating
EC. The GFR of the HK group was significantly lower than the ECleukocyte populations into the peritoneal cavity. group (40.06 6 2.31 vs. 55.58 6 6.1 P 5 0.045) and both were signifi-
cantly lower than YC (101.66 6 6.96, P 5 0.0001, P 5 0.0002). These
data suggest that HK in the elderly is a marker for ‘subclinical’ renal
disease and is due to combined defects in glomerular filtration andElevated plasma methylglyoxal and glyoxal in uraemia: implications
tubule function. Further studies are ongoing to define the mechanismfor advanced glycation end-product formation. V.M. Mann, B. Tucker1,
and spectrum of tubule cell dysfunction associated with ageing.P.J. Thomalley2, and A. Daynay, Departments of Clinical Biochemistry
and Nephrology1, The Medical School at St. Bartholomew’s Hospital,
London, UK and Department of Biological and Chemical Sciences2,
Culture and characterisation of proximal tubular cells shed into theUniversity of Essex, Colchester, UK. The mechanism of advanced glyca-
urine of children with cystinosis. S. Haq, A.S. Woolf, and W.G. van’ttion end-product (AGE) formation in uraemia is unknown. Reactive
Hoff, Nephrourology Unit, Institute of Child Health, UCLMS, 30 Guil-
dicarbonyis such as methylglyoxal and glyoxal are intermediates in ford Street, London WC1N 1EH. Cystinosis is an autosomal recessive
AGE formation and are much more potent than glucose in generating condition in which cystine efflux from lysosomes is impaired. The gene
AGEs. We therefore sought evidence of disturbed methylglyoxal and codes for a putative lysosomal membrane protein and has recently
glyoxal metabolism by measuring their plasma concentrations and the been isolated on 17p13. Patients present in infancy with the renal
activity of their detoxifying enzymes, glyoxalase (gly) I and II and the Fanconi Syndrome and later develop renal failure and multisystem
end-product, D-lactate, together with the cofactor reduced glutathione disease. There is no adequate in vitro model for the cell most severely
(GSH) in 10 nondiabetic healthy controls, sex and age matched with affected in this disorder, the proximal tubular cell. We aimed to estab-
lish an in vitro model to investigate the cell biology of cystinosis. Cellspatients with moderate uraemia (serum creatinine 183–379 mM) and
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were obtained from the urine of 5 cystinotic children who have not A computer aided erythropoietin/iron saccharate management sys-
tem—an algorithm for tailored intravenous iron therapy. D. Richard-yet received a renal transplant. These urine specimens’ cell density
was approximately 103 cells/ml. When cultured, the cells had epithelial son, C. Bartlett, C. Jones, C. Newstead, A. Davison, and E. Will, St.
James’s University Hospital, Leeds, UK. The Renal Association Stan-morphology. Further characterisation confirmed proximal tubular phe-
notype using lectin staining, immunocytochemistry and enzyme cyto- dards Group recommended .85% of patients should have a haemoglo-
bin (Hb) . 10 g/dl (pre-dialysis) after three months on haemodialysis.chemistry. Most cells stained positive with asparagus pea lectin, a
proximal tubular marker and all were negative with the distal tubular We have explored the consequences of a computer managed algorithm
of monthly EPO dose adjustment and iv iron therapy [titrated bymarker peanut lectin. In addition, immunocytochemistry using anti-
cytokeratin 20 was positive in only a very small number of cells, indicat- ferritin and RBC hypochromia (RCH%)] in 233 patients. The system
was designed to respond to signs of absolute or functional iron defi-ing minimal contamination with uroepithelium. Assays using the proxi-
mal tubular brush border enzyme gamma-glutamyl transpeptidase were ciency with intravenous iron saccharate prior to any increase in EPO
dose (100 mg/week for 8 weeks initially, then 4 3 100 mg or 4 3 50also positive, further confirming the phenotype. Finally, cystine assays
proved that these cells retain their cystinotic phenotype in culture with mg/month according to signs of iron deficiency). Once signs of iron
deficiency had been corrected (ferritin .250 or RCH% , 5%) EPOintracellular cystine levels of 10.8 to 11.4 nmol 1/2 cystine/mg protein.
Cystine levels from cultures of a commercial normal human proximal doses were increased (by 1000 IU/dose) if Hb levels fell below threshold
values. Doses were reduced incrementally at the ceiling Hb (14.0 g/dltubular cell strain (RPTEC) were 0.1 to 0.2 nmol 1/2 cystine/mg protein.
In conclusion, we have shown that cells shed into the urine of cystinotics decrease by 1000 IU/dose, and 15.5 g/dl halve dose). The population
median Hb increased from 10.0 to 11.5 g/dl [Inter-Quartile Rangeare viable and have a proximal tubular and cystinotic phenotype. These
cells can now be used as a model for biochemical studies. (IQR) 10.4–12.6 (P , 0.001)], with the proportion .10g/dl rising from
50 to 80% at six months. The RCH% fell over the 6 months from a
median of 10 to 7 (IQR 5–18 to 3–14) (P , 0.001).The ferritin fell
from a median of 248 ng/ml (IQR 150–426) to 183 ng/ml (IQR 108–275)Antioxdant status in patients on chronic haemodialysis therapy: effect
of two different membranes. M.S. Elawad, T.H. Thomas, and R. Wilkin- (P , 0.001). The EPO dose increased from 82 to 135 IU/kg/week (P ,
0.001). The predicted median annual cost for EPO rose from £2,974son, Department of Medicine (Nephrology), Medical School, University
of Newcastle Upon Tyne, NE2 4HH, United Kingdom. Chronic renal to £4,837 per patient. The management system produced a dramatic
improvement in the population haemoglobin profile over six months.failure (CRF) patients and patients with end stage renal disease
(ESRD) who undergo haemodialysis (HD) manifest increased oxida- Only routine medical and nursing time was necessary to support it.
The algorithm tailored therapy to signs of iron deficiency in individualstive stress (OS), due to inadequacy of antioxidant mechanisms includ-
ing those of the glutathione system. In this study whole blood and rather than using blanket iron supplements. This may have created a
dependence on generous EPO usage to achieve the guideline outcome.plasma total and oxidised glutathione (GSSG) were spectrophotomet-
rically determined in 15 normal controls (NC), 9 CRF patients and 16
patients on bicarbonate haemodialysis and using cuprophan membrane
(membrane A). Erythrocyte reduced glutathione (GSH) and GSSG Clinical outcomes, quality of life and costs in elderly dialysis patients:
results from the North Thames Dialysis Study (NTDS). D.L. Lamp-were calculated from the data because these cells are the major com-
partments of blood glutathione and their survival may be shortened ing1,2, N. Constantinovici3, E. Brown4, S. Harris4, P. Roderick5, L. Hen-
derson2, R. Gruen1, C. Victor6, C. Normand1, and A. Steriu, Lond Schby oxidant damage. These measurements were repeated in 9 of the
HD patients after at least 3 months on a polysulfone membrane (mem- Hyg Trop Med1, KCW Hlth Auth2, Royal Free3 Charing Cross4, South-
ampton Univ5, St. Georges6. The NTDS is a 12-mo prospective cohortbrane B) which is more compatible than membrane A. Results (mean
6 SEM) are given below. study to evaluate clinical outcomes, QOL and costs in elderly dialysis
pts. 174 pts $70 yrs on chronic dialysis (defmed according to USRDS
90 day rule) were studied: 78 incident (new) pts (IP); 96 prevalent
(stock) pts (PP). Survival hospitalisation and costs were assessed duringGSH
12-mo follow-up; QOL at B-6-12 mos, using SF-36 physical (QOL-mmol lrbcs GSSG/GSH
Phys) and mental (QOL-Ment) scores. One-yr survival rates: 78% (IP)
NC 2.3360.10 0.001 77% (PP). Cox regression analyses: for IP, # comorbid conditions (P
CRF 1.5560.07 0.0047 5 .0003) and age (P 5 .045), but not late referral (P 5 .095), sex (P
Prehaemodialysis A 1.7660.09 0.0025 5 .67) or modality (P 5 .69), were significant predictors of 1-yr survival;
Posthaemodialysis A 1.9460.09 0.0037 for PP, # comorbidities (P 5 .018) and age (P 5 .031), but not modality
Prehaemodialysis B 2.1360.12 0.001 (P 5 .48), sex (P 5 .57), tissue on dialysis (P 5 .76) or late referral
Posthaemodialysis B 2.4260.14 0.0024 (P 5 .81), were significant predictors. Subsequent regressions showed
that: for IP, hazard increased by 4.2 times in pts with peripheral vascular
disease (PVD) and 3.6 tirnes in ischemic heart disease (IHD), but
diabetes and cancer were not associated with increased hazard; forCompared to NC, erythrocyte GSH levels were significantly lower in
PP, hazard increased by 28.4 times in pts with cancer, 5.1 times in PVD,CRF (P , 0.0001) and prehaemodalysis samples of membrane A (P 5
and 4.0 times in IHD, but in diabetic pts, hazard decreased by 8.90.0003) but not in those on membrane B (P 5 0.23). Erythrocyte
times compared to non-diabetics. Compared to US general populationGSSG/GSH was significantly higher in CRF patients (P , 0.0001) and
norms for elderly people, QOL-Phys is lower than norms for 65–74prehaemodialysis samples of membrane A (P , 0.0001) but not in those
yr olds but similar to those 751 yrs, whereas QOL-Ment is comparableon membrane B (P 5 0.24). Erythrocyte GSSG/GSH was significantly
to both normative groups. Average total cost is £22,700/pt/year. Theselower in both HD groups compared to CRF patients (membrane A
findings underscore the need for health policy makers to consider theP 5 0.006, membrane B P , 0.0001). Erythrocyte GSH was significantly
higher (P 5 0.001) and GSSG/GSH was significantly lower (P , 0.0001) benefits of dialysis in the elderly.
in prehaemodialysis samples of membrane B group compared to mem-
brane A group. Comparing pre and post haemodialysis values, both
membranes induced significant increase in erthrocyte GSH (membrane Energy balance in adult haemodialysis patients. D. Fraser1, M. Keegan2,
M. Harvie 3, A. Thompson3, I. Campbell 2, P. Ackrill1, and M. Venning1,A P 5 0.0003, membrane B P 5 0.025) and GSSG/GSH ratio (P ,
0.0001 for both membranes) although posthaemodialysis GSSG/GSH Departments of Renal Medicine1, Anaesthetics 2, and of Dietetics3 With-
ington Hospital, Manchester, UK. Malnutrition has a high prevalencewas significantly lower in membrane B group (P 5 0.0012). Conclusion:
The data showed that CRF and HD patients are under increased OS. in haemodialysis patients. Previous studies have sought an increase in
energy expenditure as a cause for a net negative energy balance butBoth types of membranes induced acute OS stress but less in the long
term with polysulfone membrane as indicated by normal prehaemodial- on the whole have failed to demonstrate this (reviewed in Ikizler TA
and Hakim RM, Kidney Int 1996; 50: 343–357). We have measuredysis values of erythrocyte GSSG/GSH, probably due to its less effect
on polymorphonuclear cells, complement activation and release of energy expenditure at rest (REE) and over 4 hours dialysis or for a
4-hour time control (TxEE) by indirect calorimetry in 10 haemodialysiscytokines.
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patients (5 male) and 10 controls (4 male). All subjects were fasted Effect of non-cytotoxic anti-MHC class II antibodies on macrophage
and B cell function. E. Fosbury, K. McCormack, and R. Smith, Aca-overnight and remained fasting until the end of the study. Energy
demic Renal Unit, Southmead Hospital, Bristol. Previous work hasintake was calculated from a prospective 3-day recorded intake. The
demonstrated non-cytotoxic anti-MHC class II antibodies (OX6) tofollowing measurements were taken at the end of the session: weight,
be able to prevent autoimmune disease and prolong fully MHC mis-height, 4-site skinfold thickness and mid-upper arm circumference.
matched primarily vascularised cardiac allograft survival in rodent andMid-arm muscle circumference (MAMC) and percentage fat were
primate models. Possible mechanisms of action include inhibition ofcalculated from the anthropometric data. Basal energy expenditure
T cell priming, modulation of effector cell function and modulationwas predicted according to the Harris-Benedict equation (HB-BEE)
of T cell priming. Antibody treatment has been shown to have nofrom age, sex, height and weight.
quantitative effect on T cell priming. This work explores the effect of
antibody treatment on effector cell function. Macrophage function was
studied by examining the ability of anti-MHC class II antibodies toPatients Controls P value
inhibit i) phagocytosis of FITC conjugated E. Coli, ii) LPS and IFN-g
elicited TNFa mRNA and protein production and iii) LPS and IFN-gAge median (range) 54 (30–75) 48 (22–71) NS
elicited iNOS mRNA and nitric oxide production. No effect of anti-Height cm 16662.4 167 61.8 NS
MHC class II antibodies was seen in any of these assays. The effectWeight Kg 6965.4 64.563.4 NS
of antibody treatment on morphology of splenic lymphoid follicles wasAnthropometry
examined by immunofluorescent staining following antibody treat-MAMC cm 24.01.0 22.961.0 NS
ment. B cells were detectable in spleen at all time points after antibodyPercentage fat 26.962.7 28.6 61.8 NS
treatment. The morphology of lymphoid follicles was however signifi-Calorimetry
cantly altered by antibody treatment. B cell phenotype was examinedHB-BEE Kcal /24 h 1420673 1416 666 NS
by flow cytometry. Surface IgM and MHC class II was found to beMeasured REE Kcal /24 h 1347689 1371 681 NS
upregulated five days following antibody treatment. No effect on BTxEE Kcal /24 h 1273691 1319 686 NS
cell co-stimulatory molecules or CD40 was seen. Surprisingly B cellEnergy intake Kcal /24 h 16086119 2408 6170 ,0.001
CD19 was found to be downregulated within 2 hrs of antibody treat-
ment. Functional studies showed no effect of antibody treatment on
T cell independent antibody responses to DNP. No inhibition of totalThese data suggest that reduction in energy intake rather than in-
immunoglobulin production to auto and foreign antigen was seen.creased energy expenditure is the main cause of negative energy bal-
However, specific inhibition of IgG2a production in response to au-ance (and hence malnutrition) in adult haemodialysis patients. How-
toantigen was demonstrated. This work demonstrates simple inhibitionever, the “normal” REE of haemodialysis patients might represent a
of effector cell function (macrophages and B cells) to be inadequatemaladaptive response given that a reduced REE has been demon-
to explain the efficacy of anti-MHC class II antibodies in preventingstrated in normal subjects in response to a reduced energy intake
autoimmune disease and graft rejection. The phenotypic changes dem-(Leibel et al, NEJM 1995; 332: 621–628).
onstrated in B cells and selective inhibition of IgG2a production pro-
poses modulation of APC function as a mechanism by which T cell
priming may be influenced allowing inhibition of deleterious immune
Fractalkine mRNA expression in vivo and in vitro in human renal responses.
inflammation. P. Cockwell, C.J. Brooks, J. Girdlestone*, S.J. Chakra-
vorty, D. Adu, and C.O.S. Savage, Departments of Renal Immunobiol-
ogy and *Anatomy, Centre for Clinical Research in Immunology and Systemic IL-4 treatment does not after macrophage programming but
Signalling, Medical School, University of Birmingham and Department modulates macrophage function within nephritic glomeruli. L-P. Er-
of Nephrology, Queen Elizabeth Medical Centre, Birmingham. Fractal- wig, K.N. Stewart, and A.J. Rees, Department of Medicine and Thera-
kine was recently described as the first endothelial cell (EC)-surface peutics, University of Aberdeen, Aberdeen. It is important to understand
anchored human chemokine. It has potent differential mononuclear how macrophages develop the properties that control different stages
cell-directed adhesion and chemotactic properties and may activate of inflammation and tissue repair. Studies in vitro have shown that
mononuclear cells rolling on vascular endothelium, a critical early certain cytokines programme bone marrow derived macrophages
event in the adhesion cascade. To identify a role for Fractalkine in renal (BMDM) to develop specific sets of properties and render them insensi-
disease we have analysed mRNA expression in vivo in predominant tive to other activating cytokines (Erwig et. al., J. Immunol., in press).
glomerular (vasculitic glomerulonephritis) and tubulointerstitial (acute Here we have analysed macrophages purified from normal and ne-
renal allograft rejection) human renal disease and cytokine inducibility phritic glomeruli to ascertain whether macrophages in inflamed sites
and inhibition in renal cell cultures in vitro. A 443 bp EC Fractalkine are similarly programmed. Macrophages from normal glomeruli re-
cDNA product was synthesised by RT-PCR and cloned into a PGEM- sponded exactly like uncommitted BMDM in that they produced little
7f vector for riboprobe synthesis. By in situ hybridisation (ISH) and nitric oxide (NO) spontaneously and expressed modest amounts of
combined ISH/immunohistochemistry studies there was differential b-glucuronidase. They generate NO after priming with IFN-g followed
Fractalkine mRNA expression by microvascular and large vessel EC by activation with TNF-a and this response was abrogated by pre-
which correlated with compartment of inflammation. Further, in acute treatment with IL-4, TGF-b or TNF-a; however these cytokines had
renal allograft rejection, there was heavy expression of Fractalkine no effect when given after IFN-priming. By contrast macrophages
mRNA by proximal tubular epithelial cells (PTEC). There was no purified from inflamed glomeruli 2 and 4 days after the onset of nephri-
expression by infiltrating leukocytes and sparse presence in normal tis generated large amounts of NO spontaneously, and did not express
kidney and non-inflammatory glomerulonephritis. In vitro, semi-quan- b-glucuronidase. Treatment with IFN/TNF further increased NO pro-
titative RT-PCR showed IL-1b (20 units/ml) and TNF-a (10 ng/ml) duction, whereas IL-4, TGF-b or TNF-a had no effect. These responses
inducible Fractalkine mRNA expression by human umbilical vein EC are identical to those of IFN/TNF treated BMDM. Groups of rats
and renal cell cultures (EC 5 PTEC . glomerular epithelial cells . were then infused with rat recombinant IL-4 starting 14 hours before
mesangial cells). Further, for PTEC and HUVEC, IFN-g (200 units/ml) induction of nephritis to ascertain whether the treatment prevented
was a potent stimulant of Fractalkine mRNA expression. In studies with natural macrophage programming. The treatment resulted in a 40%
PTEC, cytokine-inducible expression was inhibited by the MAPKK-1 reduction in spontaneous NO generation by glomerular macrophages,
inhibitor PD98059 and the SAPK inhibitor SB203580. In conclusion; but did not prevent natural programming. These results are strikingly
(i) the expression patterns of Fractalkine by resident EC show that it similar to those of BMDM exposed simultaneously to IFN-g and IL-4,
is a strong candidate for directing mononuclear cell infiltration in which suggests that glomerular macrophages only become susceptible
human renal inflammation, (ii) expression by PTEC indicates a role to programming after they localise to the damaged glomerulus. We
for mononuclear cell trafficking to tubular sites and (iii) inhibition of conclude that macrophages after infiltrating an inflamed focus are
cytokine-inducible expression in PTEC suggests targeted immunosup- programmed to develop specific properties, including unresponsiveness
to alternative activating cytokines.pression may abrogate this process.
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Gene expression in cultured human mesangial cells in response to binding by 40% emphasising the critical importance of this component
(P , 0.05). Furthermore, addition of antibodies directed against theextracellular glucose as assessed by suppressive subtractive hybridiza-
tion. M. Murphy, C. Godson, F. Martin1, and H.R. Brady, Centre for monocyte integrins very late antigen-4 (VLA-4) and VLA-5 inhibited
cell adhesion to matrix by 35% and 55% respectively (P , 0.05). InMolecular Inflammation and Vascular Research, Department of Medi-
cine and Therapeutics, Mater Miseracordiae Hospital, and 1Department a further series of experiments, human monocytes were incubated
with mesangial matrix for 24 hours and cytokine concentrations in theof Pharmacology, University College Dublin, Ireland. Dysregulated
mesangial cell growth and matrix production induced by hyperglycae- conditioned medium assessed by ELISA. When compared to control
monocytes adherent to plastic, in 4 separate experiments binding tomia appears to be central to the pathophysiology of diabetic nephro-
sclerosis. The molecular basis for mesangial cell dysfunction in diabetic mesangial matrix enhanced the production of TNFa (mean 6 SEM
473.8 6 40.4 vs 82.1 6 18.6 pg/ml, P , 0.0001), IL-1b (7.7 6 1.3 vsnephropathy is still being appreciated. To further explore this issue,
we used suppressive subtractive hybridization, a PCR-based cDNA 0.6 6 0.2 pg/ml, P , 0.0001) and IL-6 (446.8 6 34.0 vs 12.0 6 2.4
pg/ml, P , 0.0001). Non-adherent macrophages removed after 2 hourssubtraction technique (Clontech), to identify mesangial cell genes that
are differentially regulated in high ambient glucose concentrations in incubation produced less than 2% of total cytokine emphasising the
critical importance of matrix binding in monocyte activation. In conclu-vitro. To this end, primary cultures of human mesangial cells were
propagated under physiological (5 mM glucose) or high glucose (30 mM sion, monocytes bind to mesangial matrix components, specifically
fibronectin. By activating these cells and enhancing their cytokineglucose) conditions for seven days. Fifty candidate cDNA fragments
representing upregulated genes were subcloned and sequenced. Seven production, this interaction may promote glomerular injury.
of these cDNA fragments encoded four genes whose induction under
high glucose conditions had previously been reported in vitro and/
or in vivo: fibronectin, caldesmon, thrombospondin, and plasminogen Exposure of primary human mesangial cells to circulating AGE-albu-
min does not cause significant release of TGF-b1, IL-1a & TNF-a.activator inhibitor-1. Twenty five cDNAs coded for genes that had
been isolated previously, but not implicated in diabetic nephropathy. M.K. Lam-Po-Tang, J.T. Kwan, and D.J. Newman. SW Thames Institute
for Renal research, St. Helier NHS Trust, Carshalton, Surrey SM5 1AA,Of the remainder, twelve cDNAs coded for sequences lodged in an
EST database and six were novel. Ten of these candidate genes have UK. Glomerular expression and release of pro-fibrogenic cytokines/
growth factors may play a role in the progression of diabetic nephropa-subsequently been analysed by northern blot analysis and induction
of eight has been confirmed in RNA extracted from cells cultured in thy (DN). The role of advanced glycosylation end (AGE) products
has been implicated in its pathogenesis in clinical studies and animalhigh glucose. Further analysis of these upregulated transcripts may
provide novel insights into the pathophysiology of diabetic nephrop- models. We therefore exposed three different human mesangial cell
(HMC) lines to AGE-human serum albumin (HSA) in serum freeathy.
medium at 20, 50 & 100 mg/ml for up to 48 hours and measured
its effects on cellular proliferation (Soluble tetrazolium assay), cell
cytotoxicity (LDH release assay) and TGF-b1, IL-1a & TNF-a releaseConnective tissue growth factor expression in human mesangial cells
exposed to high glucose. M. Murphy, C. Godson, S. Cannon, F. Martin1, (ELISA’s) in culture medium. There was a significant reduction in
cellular proliferation only at 48 hrs between AGE-HSA and HSAand H.R. Brady, Centre for Molecular Inflammation and Vascular Re-
search, Department of Medicine and Therapeutics, Mater Misericordiae control at 100 mg/ml (55% 6 5 v/s 65% 6 7, n 5 12, P , 0.05). There
was no significant difference in % LDH release at all time points andHospital, and 1Department of Pharmacology, University College Dub-
lin, Ireland. Mesangial expansion due to accumulation of extracellular at all concentrations (n 5 18) showing no difference in cell cytotoxicity
of AGE-HSA. Similarly, there was no significant change in baselinematrix is a central event in the pathophysiology of diabetic nephropa-
thy. The molecular mechanisms that subserve matrix accumulation release of TGF-b1 following exposure to AGE-HSA when compared
to controls (e.g., AGE-HSA v/s HSA control at 100 mg/ml 2111 6in this setting are still being appreciated. Here, we report that high
extracellular glucose concentrations induce mesangial cell expression 52 pg/ml v/s 65 6 45 pg/ml, n 5 9, p 5 0.125). Finally, there was no
baseline release and no novel release of both IL-1a and TNF-a byof connective tissue growth factor (CTGF), a 36–38 kDa cysteine rich
peptide which has been implicated in a variety of human fibrotic disor- HMC’s on exposure to AGE-HSA. In contrast to rat and murine
mesangial cells, exposure of HMC’s to circulating AGE-HSA in vitroders. Human mesangial cells were cultured for seven days in media
containing either 5 mM or 30 mM glucose. Suppressive subtractive does not lead to significantly altered release of TGF-b1. Nor was
there novel release of IL-1a and TNF-a by HMC’s. These resultshybridization, a PCR-based technique that allows assessment of differ-
entially induced or suppressed mRNAs, suggested induction of CTGF are confirmed on RT-PCR. However, our results do not exclude a
significant response of HMC’s on exposure to AGE-matrix proteinsunder high glucose conditions. Enhanced expression of CTGF mRNA
was confirmed by northern blot analysis. This increase in CTGF expres- or under differing experimental conditions. In contrast to rat mesangial
cells, HMC’s proliferation is only significantly inhibited at high concen-sion appeared to be a relatively specific response to high ambient
glucose concentrations and not to changes in extracellular osmolality tration of AGE-albumin. Work is currently under way to characterize
the expression of AGE-receptors in HMC’s grown under the mediaas the CTGF transcript level was not altered when mesangial cells
were cultured in the presence of 25 mM mannitol. Transforming growth conditions used above.
factor beta (TGFb), a well-defined stimulus for extracellular matrix
production in glomerular disease, is a potent inducer of CTGF expres-
Differential role for NF-kB in cytokine-mediated apoptosis: overex-sion in some non-renal cells. Using a neutralizing antibody to TGFb
pression of mutant IkBa sensitizes mesangial cells to TNF-a- but notwe have inhibited CTGF mRNA expression in response to high glucose.
to IL-1b-induced apoptosis. H. Sugiyama, J. Savill, M. Kitamura1, L.We propose that CTGF may be a modulator of mesangial matrix
Zhao, and E. Stylianou, Division of Renal & Inflammatory Disease,production within a diabetic milieu.
Dept. of Medicine, University Hospital, Nottingham, UK and Dept. of
Medicine1, University College London Medical School, London, UK.
Nuclear factor-kB (NF-kB) is a key transcription factor in cytokine-Monocyte adhesion to mesangial matrix stimulates cytokine produc-
tion. R.S. Chana and D.C Wheeler, Department of Nephrology, Univer- mediated inflammation, but the role of NF-kB in mediating pro-
grammed cell death remains unclear. Mesangial cell apoptosis may besity Hospital NHS Trust, Birmingham. The accumulation of monocytes
and their activation within the mesangium may contribute to the devel- important for the resolution of glomerulonephritis, but, if unscheduled,
contributes to progressive glomerular scarring. To elucidate the roleopment of glomerulosclerosis. These studies were designed to deter-
mine whether mesangial matrix promotes monocyte entrapment and of NF-kB in death signalling in glomerular injury, we investigated the
effect of specific inhibition of NF-kB on cytokine-induced mesangialenhances cytokine production. In previous experiments, fibronectin
was shown to augment binding of U937 monocytes to cultured human cell apoptosis. Cultured rat mesangial cells were stably transfected
with a dominant-negative mutant form of IkBa (IkB a M) CDNAmesangial cells. When the cell layer was removed by addition of 2.5
mM NH4OH and 0.1% Triton X-100, both U937 and freshly isolated which inhibits NF-kB activation. After incubation with interleukin-1b
(IL-1b) or tumor necrosis factor-a (TNF-a) without serum, apoptosishuman monocytes adhered to the underlying matrix. Pre-incubation of
matrix with a monoclonal anti-fibronectin antibody inhibited monocyte was quantified by a well-established in situ morphological assay in
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cultured mesangial cells transfected with control vector (SM43/pHb) nephropathy and help to contain the increasing number developing
or IkB a M (SM43/IkB a M). Cytosolic and nuclear proteins were ESRF. *Renal Association standard 1996: .60 years BP # 160/90, #60
extracted from the cells and analyzed by Western blot and electropho- years BP # 140/90 and ‘for certain diabetic patients these figures may
retic mobility shift assay (EMSA). Results of the apoptosis assay are need to be lower’.
shown below (mean 6 SE, n 5 5, aP , 0.05 vs serum depletion, bP ,
0.05 vs SM43/pH b).
Elevated urinary levels of monocyte chemotactic peptide-1 (MCP-1),
and soluble vascular cell adhesion molecule-1 (sVCAM-1) in human
diabetic nephropathy (DN). D. Power, G. Rush, D. Ryan, M. O’Keane,% Apoptosis after 24 hours
P. McGing, P. Coleman, and H.R. Brady, Department of Medicine and
Serum IL-1b TNF-a Therapeutics, Mater Misericordiae Hospital, University College Dublin.
depletion 10 ng/ml 10 ng/ml Approximately 25% of diabetics develop DN and the latter is the
leading cause of end-stage renal disease (ESRD) in most westernSM43/pHb 21.961.7 25.9 62.0a 26.860.7a
countries. In a survey of 500 consecutive dipstick-negative diabeticsSM43/IkBaM 20.961.7 26.8 63.2a 40.564.7a,b
attending the Mater Hospital, 21% had microalbuminuria, as deter-
mined by nephelometry, indicating a similar incidence in Ireland.
Monocytic infiltration of the glomerular tuft has recently been identi-Compared with the effect of IL-1b, TNF-a significantly increased apo-
fied in DN, and monocytes have been implicated as mediators ofptosis in SM43/IkB a M (3.5% vs 51.1 %) after 24h. Moreover, at 48h
disease progression that occurs despite correction of intraglomerularthe effect of TNF-a was dose- (53.8 6 3.2% at 100 ng/ml) and time-
hypertension with ACE inhibitors. As an initial assessment of thedependent (54.6 6 2.5%). EMSA showed that stimulation by TNF-a
mechanisms of monocyte recruitment in DN, we determined urinary(10 ng/ml) activated NF-kB in control vector cells at 24 h in parallel
levels of chemotactic cytokines MCP-1 and MCSF and the immuno-with degradation of cytosolic IkBa. However, TNF-a did not activate
globulin superfamily adhesion molecule VCAM-1 in a) control subjects,NF-kB in SM43/IkB a M cells which constitutively expressed mutant
b) microalbuminurics, c) dipstick-positive proteinurics and d) ESRDIkB a protein. In contrast, treatment with IL-1b (10 ng/ml) did not
patients on dialysis. Urine MCP-1 and sVCAM-1 levels were enhancedactivate NF-kB either in SM43/pHb, or SM43/IkBa M at 24h. These
in DN (P , 0.05) and appeared to correlate with the degree of protein-results demonstrate for the first time that NF-kB activation plays an
uria and renal compromise. Interestingly, urinary MCP-1 levels wereinhibitory role in TNF-a mediated death signalling of mesangial cells.
elevated even during the microalbuminuric stage and preceded changesA different signalling pathway regulates IL-1-induced apoptosis.
in sVCAM-1. Urinary MCSF levels were found to be reduced in DN
patients compared with controls (P , 0.01) perhaps reflecting increased
clearance of the chemokine in this condition. Plasma levels of MCP-1There is room for improvement in the management of established
and sVCAM-1 did not differ among patients with DN and controldiabetic nephropathy. I. Dasgupta, N.D.C. Sturrock1, J. Savill 2, S.D.
subjects (P , 0.01) suggesting intrarenal generation of these mediators.Roe, and R.P. Burden, Renal Unit and Diabetes Unit1, Nottingham City
Complementary in vitro and in vivo approaches are ongoing to furtherHospital; and Dept. of Medicine2, University Hospital, Nottingham, UK.
define the mechanisms and pathophysiological significance of chemo-Diabetic nephropathy is the commonest cause of end stage renal failure
kine release and adhesion molecule upregulation in DN.(ESRF) in the Western world accounting for up to one third of cases
and it is well established that strict glycaemic and blood pressure
control along with the use of ACE inhibitors can slow its progression.
Microalbuminuria as a predictor of glomerular disease and renal prog-We reviewed all patients (n 5 35, 25% of ESRF cases) labelled as
nosis in patients with microscopic haematuria. K. Eardley, A. Ma-diabetic nephropathy residing in a single health district who joined
jumdar, M.A.S. Ferrreira, A.J. Howie, N.T. Richards, C.O.S. Savage,our dialysis programme over the last 3 years. Median age was 57 years
D.C. Wheeler, D. Adu, and G.W. Lipkin, Queen Elizabeth Hospital,(range 24–78), 27 males and 8 females, 14 IDDM and 21 NIDDM.
Birmingham. Factors that predict glomerular disease and subsequentThe following items relating to chronic renal failure were assessed at
progression to renal impairment in patients with microscopic haematu-the time of referral to renal clinics:
ria are unclear. We made two studies looking at such a population.
Between 1995 and 1997, 137 unselected patients with microscopic
haematuria (M/F:61/76), age 43 6 (SD) 12, and preserved renal func-Glycaemic control at referral
tion (serum creatinine 93 6 13 mmol/L), underwent renal biopsy afterHb A1C 4–7% 21%
appropriate urological investigation. Urine albumin excretion (UAE)Hb A1C 7–8% 22%
was normal in 78 (57%) of patients, 38 (28%) had microalbuminuriaHb A1C .8% 57%
(30–300 mg/24 h), and 21 (15%) macroalbuminuria (UAE . 300 mg/Mean BP over total period of hypertension treatment
24 h). Those with macroalbuminuria are not considered further for.130/85 mm Hg* 100%
the purposes of this study. Renal histology in the 78 patients with.140/90 mm Hg 84%
normal UAE, indicated thin glomerular basement membrane (GBM).160/90 mm Hg 56%
disease (78%), normal (8%) and IgA nephropathy (14%). Of the 38Not on ACE inhibitors 34%
patients with microalbumuria, renal biopsy revealed thin GBM disease(ACEi used but stopped) 11%
(53%), IgA (40%), and others (7%). To determine long term renalMedian no. of antihypertensives used 2 (range 1–5)
prognosis, we reviewed records of 49 patients with microscopic haema-Serum creatinine at referral lmol /l
turia and normal creatinine (29 normal urine protein excretion (UPE).250 (Renal Association standard 1996) 91%
(,200 mg/24h),) who underwent renal biopsy between 1984 and 1987..350 60%
.500 31% At light microscopy, glomerular abnormalities were seen in 24% and
Time from referral to ESRF 85% of patients with normal or elevated UPE respectively. Over a
,3 months 29 mean of 9.6 years, no patients with normal UPE as compared with 5
3–6 months 17% (25%) of those with abnormal UPE developed renal impairment, (2
6–12 months 40% (10%) dialysis dependent). 4 of the 5 patients had IgA nephropathy.
.12 months 14% In patients with microscopic haematuria, normal UAE is strongly asso-
Median time from onset of proteinuria to ESRF ciated with the presence of thin glomerular basement membrane dis-
years (range) 6.8 (1.9–20.8) ease but significant glomerular disease is common in patients with
microalbuminuria. Patients with microscopic haematuria and normal
urine protein excretion have an excellent long-term renal prognosis.
Renal biopsy may not be indicated in patients with microscopic haema-These findings highlight the need for closer collaboration between
nephrologists and diabetologists to improve management of diabetic turia and normal urinary albumin excretion.
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Frequently-relapsing steroid-sensitive nephrotic syndrome: from chil-
Serum creatininedren to adulthood. F. AlBaaj, X.N. Chen, P.A. Kalra, N.J.A. Webb1,
Number at 1 year lmol /lM. Lewis1, R.J. Postlethwaite1, D.J. O’Donoghue, and S. Waldek. Depts.
of Renal Medicine, Hope Hospital, Salford and Paediatric Nephrology, SCARRF 40 14469.2*
The Royal Manchester Children’s Hospital1, Manchester. There is con- ARF 41 192622.5*
siderable debate concerning the long-term clinical progress of children
*P < 0.05with frequently-relapsing, steroid-responsive nephrotic syndrome.
Some studies suggest that the frequency of relapses markedly dimin-
ishes once adulthood is reached but Tejani has shown, albeit in a group
of children with a unique racial case-mix, that morphological transition
to focal segmental glomerulosclerosis (FSGS), with the risk of subse- and, at the same time, acute renal failure requiring RRT. We compared
quent renal impairment, can develop in over 60% of these patients. 100 patients who had SCARRF with 100 patients (age and sex matched)
We studied 11 patients (8 males, 3 females; ethnic background—10 who had ARF and required RRT only. The most common causes were:
caucasians, 1 asian), mean age 21 6 3.4 years, who had initially pre-
sented (at mean age 5.4 6 2.6 years, range 2–14) to a tertiary paediatric
referral centre with nephrotic syndrome, and who were then trans-
Diagnosis SCARRF ARFferred to the adult nephrological service after their condition had
continued to relapse in early adulthood. Relapses had been treated Sepsis 29 15
with courses of high-dose oral prednisolone, and where necessary, Surgery 28 11
other standard immunosuppressants. The histological diagnoses were Drugs 12 10
minimal change disease (9) and FSGS (2). Mean follow-up was 15.6 Glomerulonephritis 2 21
years (range 10–20). Up to the age of 16 years patients had 5.3 6 2.0 Urology 3 13
(range 2–8) nephrotic relapses per year, whereas this fell to only 0.9 Vasculitis 5 4
6 0.7 (range 0–2) relapses per year in their follow-up after this stage. Others 21 26
All patients had been biopsied at least twice during the course of their
disease and no histological transformation had been observed. None of
the patients developed hypertension or renal impairment. Our findings Each group was assessed for overall survival, renal prognosis, comor-would suggest that an excellent renal prognosis should be anticipated bidity, serum creatinine at one year or need for chronic RRT. Thefor children presenting with frequently-relapsing steroid-sensitive ne- mean age in each group was 56 years. There were 59 males and 41phrotic syndrome. The likelihood of a frequently-relapsing course ap- females in each group. There was a 45.5% (91/200) survival at onepears to diminish rapidly once adulthood is reached and histological year. The distribution of those who died is shown below:transformation to a more aggressive renal pathological lesion was not
observed.
Number Mean weeks to death
Increased incidence of renal disease in silica exposed workers. John SCARRF 58 2.960.43
Main and Sean Fenwick, Renal Unit, South Cleveland Hospital, Mid- ARF 51 5.061.10
dlesbrough. Various types of glomerulonephritis may occur more com-
monly in people exposed to silica, and patients commencing dialysis
are more likely to have been exposed to silica than matched controls.
81 of the survivors were independent of dialysis at 1 year. 10 of theWe describe an increased incidence of renal disease in an isolated
survivors required chronic RRT (1 SCARRF, 9 ARF). The renal func-community which appears to be related to silica exposure. The cases
tion of those independent of dialysis is shown below:included are only those known to nephrologists at the time we first
There were more ARF patients with neoplasia (17 vs 8) but the timebegan to investigate the possibility of increased incidence. The area
from presentation to death was longer in this group. Other comorbidin question is a mining community with a population of 1645. Eight
conditions (ischaemic heart disease, chronic obstructive pulmonaryof them are known to have renal disease. This compares with 2 cases
disease, diabetes, peripheral vascular disease, cerebrovascular disease)out of the other 5600 population of that GP practice catchment area
occurred in similar frequencies in both groups. The prognosis in each(p 5 0.004), and with 156 patients attending the district renal OP clinic,
group is similar. The time from presentation to death is longer in thefrom a catchment population of 130,000. Six of the eight cases have
ARF group. This suggests that the failure of a second major system,some form of glomerulonephritis, an incidence of 4.25 per thousand,
and the requirement for ventilation should not exclude such patientscompared with 47 at the district renal clinic, an incidence of 0.36 per
from renal replacement and other aggressive supportive therapy, de-thousand. Two have normal serum creatinine and four have chronic
spite the greatly increased costs.renal failure, progressive in two. Two are on renal replacement therapy,
compared with a prevalence of 410 pmp for the district and 452 for
the parent Renal Unit. Of the eight cases, 3 have a positive PANCA,
A novel modulator of the immune response. G.M. Lord, R.J. Baker,one IgA disease, one membranous and one membranoproliferative
J.K. Howard1, G. Matarese, S.R. Bloom1, and R.I. Lechler, Departmentsnephritis. At least six of the cases were occupationally exposed for
of Immunology and Endocrinology, Imperial College School of Medi-years to silica dust. The gap between ceasing exposure to silica and
cine, Hammersmith Hospital1, Du Cane Road, London, W12 0NN,developing clinically evident renal disease ranged from 0 to 30 years,
United Kingdom. Leptin is a 16 kDa adipocyte derived hormonein keeping with reports in the literature. These cases are further evi-
thought to be important in the regulation of body weight and energydence that exposure to silica can cause various types of glomerulone-
metabolism. The data presented here show that leptin acts as an immu-phritis, most commonly ANCA-related vasculitis. We have reported
nomodulator of both antigen-specific and alloantigenic T cell responsesour findings to the local Health and Safety Executive and Department
by differential regulation of naive and memory T cells. This phenome-of Public Health, and hope to start systematically investigating the
non has also been studied in vivo. Our findings suggest a novel role forpopulation of silica-exposed workers.
leptin in linking nutritional status to cognate cellular immune function
(Nature–in press). Leptin is cleared from the circulation, in part, by
the kidney. We have previously demonstrated that patients with end-A comparison between 100 patients with severe combined respiratory
stage renal failure have elevated leptin levels (Clin Sci 93, 119–126,and renal failure (SCARRF) and 100 patients with acute renal failure
1997), and leptin is generating increasing interest amongst nephrolo-(ARF) requiring renal replacement (RRT) only. A.V. Crowe, E.L.
gists. This axis of control of immune responses may have importanceAbdelgadir, R. Rustom, P.S. Williams, and J.M. Bone, The Renal Unit,
in the design of novel immunosuppressive regimes for both organRoyal Liverpool University Hospital, Liverpool, UK. SCARRF is de-
fined as respiratory failure requiring artificial ventilation of the lungs transplantation and the therapy of autoimmune disease.
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Levamisole acts by altering Th1.Th2 cytokine balance. C.C. Szeto and fibroblast growth factor (bFGF) has been implicated as a major growth
factor involved in fibroblast activation and extracellular matrix synthe-P.W. Mathieson, Academic Renal Unit, University of Bristol, Academic
sis and in many cells the activity of bFGF is controlled by a low affinityRenal Unit, Southmead Hospital, Westbury-on-Trym, Bristol, BS10
interaction with cell surface heparan sulfate (HS) proteoglycans (PG)5NB. Levamisole is an immunomodulatory drug whose mode of action
of the syndecan family. These molecules are likely, therefore, to beis unexplained. In minimal change nephropathy (MCN), levamisole
central to the control of interstitial fibrosis but as yet there has beensuccessfully maintains remission in a proportion of patients. MCN is
no characterisation of their expression on interstitial cells. The presentassociated with atopy, allergy and raised serum IgE, suggestive of a
study reports the in vitro characterisation of syndecans expressed bybias towards the Th2-type of immune response. Our hypothesis is that
the rat renal fibroblast line NRK 49F. RT-PCR of mRNA from growthlevamisole exerts its effects by resetting the biased Th2 response; it
arrested NRK 49F demonstrated the specific expression of syndecanscould achieve this either by suppressing an overactive Th2 response
1,2,3 and 4. Syndecan-1 MRNA, and to a lesser extent that for syndecanor by boosting the counter-regulatory Thl response. We have tested
4 was upregulated in response to low concentrations of serum (0.5%),the hypothesis using a rat strain heavily predisposed towards a Th2-
reaching a peak at 9–24 hr. Treatment with BFGF (5 ng/ml) alsotype response, the Brown Norway (BN) rat. Ten BN rats were treated
induced Syndecan-1 MRNA with peak expression by 30 min. Therewith levamisole by intraperitoneal injections of levamisole ranging
was no effect of either stimulus, however, on syndecan 2 or 3 MRNAfrom 0.0625 to 25 mg/kg/day. Blood samples were taken on days 1, 3,
expression. To examine the expression of the syndecans on the cell5, and 8. Another 8 BN rats received levamisole 25 mg/kg/day intra-
surface, fibroblasts were metabollically labelled for 24 hr with [35S]-peritoneally; and 2 were killed on days 1, 3, 5, and 8, with total splenic
sulphate. The cell surface PG were extracted with 0.2% Triton X-100RNA extracted. Serum samples were assayed for gamma-interferon
(with proteinase inhibitors), and passed over DEAE-Tris Acryl. Ap-(gIFN). Expression of various Thl and Th2 cytokines were analysed
proximately 47% of the cell surface PG were HS following digestionby RT-PCR on splenic RNA. Levamisole treatment led to dose-depen-
with chondroitinase ABC. Furthermore under proliferating conditionsdent induction of gIFN in serum (from 365.8 6 16.5 pg/ml on day 0
there was a marked increase (7–10 fold) in total cell surface HSPGto 1463.4 6 140.2 pg/ml on day 3 with 25 mg/kg/day), followed by
expression but no change in the ratio of HSPG to other proteoglycans.“rebound” recovery towards baseline level by day 8. Cytokine gene
To demonstrate changes in core protein expression, cells were labelledexpression showed similar trend of gIFN and IL-18 up-regulation on
with [35S]-methionine/cysteine for 24 hr. There was a similar 8–10 foldday 3 followed by recovery towards baseline. Splenic IL-4 mRNA
increase in HSPG core protein expression under proliferating condi-expression went down after levamisole, while IL-12 did not change.
tions. The present study demonstrates that the increased expressionWe conclude that levamisole is capable of suppressing a biased Th2-
of cell surface HSPG was associated with the proliferation of renaltype immune response: our results support the hypothesis that this is
fibroblasts. Syndecan expression may therefore play a major role inits mode of action in MCN and suggest that design of more selective
the development and persistence of a proliferating phenotype duringand/or more powerful drugs to act in this way would offer potential
interstitial nephritis.new therapies for MCN.
Late referral for renal replacement therapy in the South West Region—
Serum cystatin C concentrations in renal transplant recipients. T.D. how common is it and what are its determinants and sequelae? P.
Leach, C. Kitiyakara, H. Thakkar1, H. Finney1, J.M. Stevens, and D.J. Roderick1, N. Drey1, P. Webster1, S. Blakely2, J. Mason2, and C. Tomson
Newman2, Wessex Renal & Transplant Unit, St. Mary’s Hospital, Ports- 3, 1Wessex Institute of Health Research and Development, Southampton
mouth, Department of Clinical Biochemistry1, St. Bartholomew’s and University; 2Wessex Renal unit, Portsmouth; 3Southmead Renal unit,
the Royal London School of Medicine and Dentistry, London, SW Bristol. Previous studies have shown that late referral of patients is a
Thames Institute for Renal Research2, St. Helier Hospital, Carshalton. common problem, associated with poorer outcomes and higher shorter
Cystatin C (cysC), a 13kD protein, is produced at a constant rate by term costs. Opportunities for active management of the clinical conse-
all nucleated cells. It is completely filtered by the glomerulus and quences of chronic renal failure and elective planning for the start of
metabolised by proximal tubular cells. Compared with 51Cr-EDTA dialysis may be lost. It is not clear to what extent this problem is
clearance, serum cysC concentration is a reliable and accurate marker inevitable or avoidable and if so by what means? Data are presented
of glomerular filtration rate (GFR). It is better than serum creatinine, from a comprehensive retrospective survey in one region, part of a
b2-microglobulin, a1-microglobulin, and retinol-binding protein at es- wider project including prospective confidential enquiry of referrals
timating GFR, and is assayed using a multichannel analyser. We studied in two units. A structured retrospective case note review of all cases
serial serum cysC concentrations (latex PETIA assay) in 21 consecutive starting renal replacement therapy in all 6 renal units in the South and
renal transplant recipients. Nine uncomplicated patients had prompt West Region 1.6.96–31.5.97 considered to be due to chronic renal failure.
378 cases were identified and 367 (97%) notes were retrieved, 341 (90%)reduction of serum creatinine and cysC concentrations. CysC corre-
had useable data. The median age was 62 and 60% were male. Thelated with creatinine (r2 5 0.52, P , 0.0001), better at lower creatinine
median number per unit was 42 (range 27–126). Patient numbers byconcentrations (r2 5 0.40, P , 0.0001 when creatinine # 550 mmol/l)
time from referral to dialysis: 0–4 months, 126 pts (37%); 5–12 months,than higher (r2 5 0.041, P 5 0.52 when creatinine . 550 mmol/l).
56 pts (17%); 1–5 years, 103 pts (30%) and 51 years, 54 pts (16%).Twelve patients had complications, including delayed graft function
The proportion of late referrals (here 0–4 months) ranged from 15%(11), acute rejection (5), urine leak (3), cyclosporin toxicity (2) and
to 50% by unit. Comparison of early and late showed the following.clot obstruction (2). In acute rejection, cysC rose earlier and fell more
Median age: late referral (LR) 66, early referral (ER) 58; % male: LRpromptly with treatment than creatinine, and was not altered by low-
58, ER 61; % diabetic: LR 25, ER 15; Mean SCr at 1st dialysis: LRflux dialysis. CysC also fell in urinary leak, where creatinine did not.
900 umol/l, ER 859 umol/l (not signif.); Mean serum albumin at 1stAt three years follow-up 16 patients were still alive, 15 with functioning
dialysis: LR 33, ER 36 (P , 0.001). 60% of LR compared to 32% ofgrafts. There was no correlation between discharge concentrations of
ER had an emergency start to dialysis. Only 30% of LR had permanentcysC and creatinine with 3-year creatinine concentrations, or with
access established, compared to 67% of ER. 63% of LR had a prior3-year graft survival. We conclude that serum cysC is comparable with
known history of CRF at referral compared to 48% of ER.creatinine for monitoring primary renal transplant function. It shows
more prompt changes in acute rejection, which are not masked by
dialysis. Further studies are required to clarify the role of cysC in
complicated renal transplantation.
Referral source Late referral Early referral
GP 21 (17%) 83 (41%)Fibroblasts from the cortical interstitium express cell surface heparan
General physician 43 (36%) 55 (27%)sulphate proteoglycans. Aled Clayton, Janet Thomas, Gareth Thomas,
Other nephrologist 26 (21%) 15 (7%)Malcolm Davies, and Robert Steadman, Institute of Nephrology, Royal
Surgeon 7 (6%) 15 (7%)Infirmary, Cardiff. While the regression of renal disease to end stage
Other 25 (20%) 36 (18%)is strongly correlated with tubulointerstitial changes, the control of
Overall x2 showed significant differences between LR and ER (P , 0.001).the fibrotic process within the interstitum is poorly understood. Basic
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Further data will be presented on comorbidity and prior treatment. tial care options and service configurations. The model is used live
during the workshop to provide an immediate view of the impact ofPatients referred late are common and are older having more diabetes
and poorer serum albumin. They are more likely to start dialysis as different planning assumptions and enabling a wide range of options
to be explored quickly. The model predicts service levels (e.g., numbersan emergency and have a prior history of CRF. Differences in referral
were found for LR cases with more from General Physicians, nephrolo- of stations), staff numbers as well as costs but also includes a quality
routine which is allocated by clinical staff. The model has been em-gists and less from GPs. Further, prospective, work is needed to illumi-
nate the processes of referral. ployed in the local planning area to examine the future need and the
consequences of the development of a satellite unit and the use of
APD. The wider issue of the role of the model and the workshop in
the planning process will be presented.Does clenbuterol affect whole body protein turnover in adults with
end-stage renal failure managed by CAPD? C.H. Jones1, T.H.J.
Goodship2, K. Bartlett3, and C.G. Newstead1, 1Department of Renal
Medicine, St James’s University Hospital, Leeds, UK, 2Department of Cystatin C; progress towards a replacement for serum creatinine. H.
Finney*, D.J. Newman, C.W.G. Redman*, C.P. Price, S.W. ThamesRenal Medicine, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK,
3Biomedical MS Unit, University of Newcastle, Newcastle-upon-Tyne, Institute for Renal Research, St. Helier N.H.S. Trust, Surrey and St.
Bartholomew’s & The Royal London, London, UK*. Cystatin C hasUK. Clenbuterol is a beta-2 adrenoreceptor agonist that is anabolic
in experimental animals, both in health and in disease models. The received considerable attention over the last few years as a potential
replacement for creatinine as a biochemical marker for GFR. Severalincrease in protein (predominantly skeletal muscle) mass has been
attributed to both an increase in protein synthesis and a decrease in groups, including our own, have demonstrated improved sensitivity to
early renal damage. However, without a comprehensive evaluation ofprotein degradation. There are no data on protein turnover in response
to clenbuterol in humans, either in health or disease. This study investi- a reference range its practical use might not be realisable. We set out
to measure cystatin C in 70 neonates, 182 adolescents, and 309 adults,gates the in vivo effect of clenbuterol on whole body protein turnover,
as determined by [1-13C]-leucine turnover, in adult subjects with ESRF equally distributed between males and females. Serum cystatin C was
measured using the DadeBehring BNA II method.treated by CAPD. Five adult subjects (4 male) were investigated in a
double blind placebo-controlled crossover study of clenbuterol (40 mg/
day orally) or placebo, each given for seven days. The two treatment
periods were separated by a 1 week ’wash-out’ period. Oral calorie Reference ranges for serum cystatin C
and protein intake were estimated from a day food diary over the final
Age n 95% CI3 days of treatment. Subjects were investigated in the fed state. Mean
age was 47 6 12 yrs and renal failure was due to hypertensive nephro- ,1 year 70 0.69 to 2.06 mg/l*
sclerosis (2 cases), chronic pyelonephritis (2 cases) or chronic glomeru- 1–17 years 182 0.51 to 1.27 mg/l
lonephritis (1). Whole body protein synthesis and degradation (units: .17–,50 years 258 0.53 to 0.92 mg/l
g protein/kg/day) were estimated by leucine turnover on the seventh .50 years 51 0.58 to 1.02 mg/l
day of each treatment period and the results (6 SD) are shown in the
* Log transformedtable. Venous bicarbonate was in the normal range and did not change
during the study (clenbuterol phase 23.3 6 1.3 mmol/l; placebo phase
23.6 6 0.6 mmol/l). Although statistical differences were apparent between male and fe-
males the average difference was ,0.1 mg/L, supporting the use of a
single reference range for men and women. Neonatal distribution of
cystatin C concentrations reflected the known maturation in GFR,Phase Turnover Synthesis Degradation
whereas creatinine concentrations initially reflect a maternal influence
Clenbuterol 3.4861.42 2.77 61.00 1.62 60.95 and then, after falling, rise in parallel with muscle mass. Cystatin C
Placebo 3.1360.96 2.37 60.55 1.27 60.55 concentrations reach adult concentrations by about 1–2 years of age,
creatinine concentrations do not achieve this until late adolescence.
In a preliminary study we collected maternally and gestationally age
No significant differences were detected (paired t test). Body weight, matched samples from 20 normal subjects and 20 who went on to
dietary protein and calorie intake, and serum urea and albumin were develop pre-eclampsia. Both serum cystatin C and creatinine concen-
also unchanged. Therefore, oral clenbuterol at the normal therapeutic trations were significantly different (P , 0.001) between pre-eclamptic
dose for asthma (40 mg/day) has no demonstrable effect on protein metab- and normal samples but the elevation in cystatin C was particularly
olism in adult patients with chronic renal failure maintained on CAPD. marked with a 72 vs 29% increase for creatinine. Although further work
is still required, the establishment of comprehensive reference data and
a further clinical indication of improved sensitivity to renal damage
Strategic planning of renal services: development of a model to facili- add weight to the claim that cystatin C is becoming a viable replacement
tate the planning process. P.A. Rutherford and P. Forte1, University of for serum creatinine.
Wales College of Medicine, Wrexham Maelor Hospital and 1University
of Keele, UK. Planning for renal services is difficult and faces new
problems with financial restraints and the formation of primary care Cardiac Troponin T (cTnT) levels in a chronic haemodialysis popula-
groups. Patient dependency, co-morbid disease, distance from existing tion are not associated with known ischaemic heart disease. H. Lach-
services and the availability of dialysis techniques have implications mann, S. White, G. McCreanor, P. Stubbs and A. Davenport, Center
for the organisation and cost of dialysis services. Additional factors, for Nephrology, Royal Free Hospital School of Medicine, London UK.
important to clinical staff, include performance of clinically effective It has recently been shown that cTnT measured by the current ELISA
dialysis and preservation of patient choice of dialysis modality. We have assay (cut off 0.1 ng/ml) reflects true cardiac damage rather than a
developed a spreadsheet-based planning model for chronic dialysis skeletal muscle origin. Elevated levels of cTnT are reported in 10–40%
services. Patients are subdivided and allocated to dependency groups of the HD population and may have prognostic significance for future
according to the Renal Association co-morbidity scoring system and cardiac events. One postulated mechanism by which this could occur
their traveling time to the renal unit. The facilities, services and staff is recurrent HD-related myocardial cell injury. We studied 129 patients
involved in each dialysis modality offered by the renal unit are identi- who had been on HD for a mean of 4.7 [7.86] yrs of whom 29 [22.4%]
fied (with their costs) and then quantified for each of the patient had a predialysis cTnT of .0.1 ng/ml. There was no significant rise
dependency groups. Each variable can be changed according to local post dialysis [99.2% concordance between pre and post cTnT]. On
factors and new desired treatment options (e.g., satellite haemodialysis) statistical analysis by chi squared test the presence of positive cTnT
can be modelled. The model has been designed as an integral part of values showed no significant correlation with patient age, years on
a planning workshop which brings together clinical and non-clinical HD, Kt/V, PTH, haematocrit, hypertension, intradialysis hypotensive
episodes or known ischaemic heart disease. There were significantprofessionals to explore the consequences of different actual or poten-
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associations with diabetes [P . 0.001] and with lower serum cholesterol Culture and Characterisation of Human Renal Distal Tubular Cells.
T. Carr1,2, P.R. Evans3, J.D.M. Albano4, S.K. Campbell4, S. Terry2, P.than controls [P 0.025]. Using the cTnT lower detection limit of 0.06
Bass2, 1Wessex Renal and Transplant Unit, St. Mary’s Hospital, Ports-ng/ml, 57 patients [44.2%] were analysed [mean age 59.63 (13.26 cf.
mouth, University Departments of 2Pathology and 4Medicine and 3Re-52.05 (18.44 in controls]. There were significant associations with diabe-
gional Immunology Service, Southampton General Hospital. Tubulartes [P . 0.001], patient age [P 0.01], intradialysis hypotension [P 0.0446]
cells of the distal nephron which synthesise and excrete componentsand IHD [P 0.0125] but none of the other variables studied. We found
of the vasodilatory kallikrein kinin system (KKS) are susceptible tono rise in cTnT [corrected for haematocrit] following HD and thus no
damage by a variety of nephrotoxins, including drugs used for immuno-support for a direct HD related response. Evidence for an association
suppression. An imbalance of vasoactive hormones as a result of suchwith known IHD is at best equivocal; larger studies and long term
damage is thought to be a contributory factor to the hypertension thatfollow up are required to determine the cause of raised cTnT in HD
often accompanies the use of these drugs. In order to investigate thepatient and its significance.
mechanisms involved in the release of components of the KKS from
distal tubular cells and the effects of tubular toxins we aimed to main-
tain human tubular cells in culture and to obtain enriched populations.
Modelling the future requirement for satellite dialysis units in the Human renal tubular cells derived from nephrectomy specimens were
Northern region using a geographic information system (GIS). M. grown to confluence in Waymouth’s Medium plus 10% foetal calf
Walmsley, M.E. Charlton, D. Bennett-Jones, M. McHugh, R. Wilkinson, serum. The mixed tubular cells were shown by immunocytochemistry
J.A. Main, and T.H.J.Goodship, Departments of Medicine and Geogra- and flow cytometry to express low molecular weight cytokeratin
phy, University of Newcastle upon Tyne and Renal Units at Cumberland (CAM5.2) and HLA class I (W6/32) but not HLA class 11 (WR18).
Royal Infirmary, Sunderland Royal Infirmary and South Cleveland In addition between 10 and 30% of the mixed populations expressed
Hospital. The demand for haemodialysis in the UK continues to esca- epithelial membrane antigen (EMA-E29/68). Using EMA and immu-
late; to accommodate this many renal units have established satellite nomagnetic beads two populations of tubular cells were isolated. Kalli-
krein levels were measured in three tubular cultures by RIA as kinino-dialysis units usually on a hospital site in an urban area. Although
genase activity. Kallikrein content of mixed tubular, EMA1ve andcommon sense will often dictate the site of such units, political factors
EMA2ve cells were as follows:can also have an impact. In the Northern Region there is currently
only one such unit in Darlington the other dialysis units being in
Newcastle, Sunderland, Carlisle and Middlesbrough. The aim of this
study was to assess whether a geographic information system such as
Arc/Info could be used to determine the most appropriate sites for
future satellite units. The post codes of all patients undergoing treat-
ment with haemodialysis, CAPD and renal transplantation were used
to map the location of all patients who potentially might require haemo-
dialysis in the future (see figure). Using Arc/Info potential sites were
chosen that satisfied the following criteria 1. Current hospital site 2.
At least 18 potential patients. 3. Travelling time of no greater than 60
minutes for each dialysis.
These results show that cells of high kallikrein content suitable for
further release studies can be isolated from a mixed population of
renal tubular cells and that EMA1 cells are of distal tubular origin.
The role of endogenous steroid hormones in the regulation of mercuric
chloride induced autoimmunity in Brown Norway rats. I.A.M.
MacPhee, D.R. Turner, and D.B.G. Oliveira, Renal Medicine, St.
George’s Hospital Medical School, London, UK. Injection of Brown
Norway rats with mercuric chloride (HgCl2) activates a Th2-type auto-
immune response with production of a number of autoantibodies in-
cluding antiglomerular basement membrane and ANCA, and vasculitis
primarily affecting the gut. Glucocorticoids have been shown to sup-
press Thl and to promote the development of Th2 type responses.
Conversely dehydroepiandrosterone (DHEA) promotes Th1 re-
sponses with suppression of Th2 responses. This study set out to define
the role of these hormones in this animal model. Rats were adrenalec-
tomised (Adx) with no steroid replacement (n 5 11), Adx with basal
steroid replacement given by a 25 mg corticosterone pellet inserted
subcutaneously (n 5 13) or sham Adx (n 5 14) prior to administration
Figure: Solid lines represent modelled “catchment” areas for each ex- of HgCl2. In both groups of adrenalectomised animals there was a
isting dialysis unit. Half tone lines are the boundaries of the administra- delay in the production of IgE and serum levels on day 10 were margin-
tive counties. Each small square represents at least one patient. ally lower: 0.21 6 0.09 mg/ml (mean 6 SD) for sham Adx vs 0.14 6
0.06 mg/ml for Adx with steroid replacement and 0.16 6 0.08 mg/ml
for Adx with no replacement (P 5 0.035, repeated measures ANOVA).
Using this model two initial sites satisfied these criteria, Bishop Auck- All of the animals Adx with no steroid replacement and 2 Adx animals
land and South Shields. Arc/Info is a powerful GIS and potential sites with replacement died between 10 and 14 days after HgCl2 challenge
identified using this program will obviously depend upon the inclusion presumably due to failure to suppress cytokine production. There was
criteria used but this study does demonstrate that it is possible using no difference in the severity of caecal vasculitis between the groups.
GIS to determine the site of future satellite units in a logical and A significant increase in adrenal size was noted following administra-
tion of HgCl2: Median 0.17 mg/g rat weight in control animals (n 5“scientific” way.
Abstracts 2591
11) and 0.29 mg/g in adrenals removed 12 days after first administration and ethnically homogenous population. Pauci-immune RPGN is part
of HgCl2 (n 5 5). Mann-Whitney U P 5 0.002. This experiment has been of a continuum of vasculitic illness.
repeated once with similar results. Administration of subcutaneous
DHEA implants (100 mg and 200 mg) had no significant effect on
IgE levels or severity of vasculitis. These observations suggest that Acute tubulointerstitial nephritis—a clinicopathological study of 22
corticosterone and DHEA do not play a central role in the evolution patients. R.J. Baker, A.D. Salama, A.N. Chaudhry, H.T. Cook, and C.D.
of HgCl2 induced autoimmunity but corticosterone has a minor influ- Pusey, Renal Section, Department of Medicine, ICSM, Hammersmith
ence on IgE production and corticosterone deficiency results in fatality Hospital, Du Cane Road, London, W12 ONN. Tubulointerstitial ne-
at the time of peak disease. phritis is found in up to 25% of native renal biopsies, and is an important
cause of acute renal failure. We describe the clinical presentation,
morphological findings and outcome of 22 consecutive patients from
European vasculitis trials: a progress report. G. Gaskin1 and D. Jayne2 a single centre, presenting between 1985 and 1997. Acute tubulointer-
on behalf of the European Vasculitis Study Group, Renal Section, ICSM, stitial nephritis (ATIN) was defined as acute loss of renal function
Hammersmith Hospital, London, UK1 and St. George’s Hospital Medi- with normal sized kidneys on ultrasound, and a renal biopsy showing
cal School, London, UK2. The multidisciplinary European Vasculitis tubulointerstitial inflammation, tubulitis and no evidence of glomerulo-
Study Group (EUVAS) is conducting clinical trials in ANCA-associ- nephritis. The diagnosis was suspected clinically in only 45% of cases
ated vasculitis (AASV). A first wave of randomised trials commenced emphasising the need for biopsy. There was infrequent evidence of
in 1995. CYCAZAREM (azathioprine vs cyclophosphamide for main- “inflammatory” signs or symptoms. Arthralgia occurred in 13% of
tenance of remission) ceased recruiting in 1997 and will be analysed patients, fever in 34%, and rash in 26%. Eosinophilia occurred in
in early 1999. MEPEX (plasma exchange vs methylprednisolone for only two patients. The aetiology was drug related in 12 cases, mostly
severe nephritis in AASV) has recruited 88/150 patients required; following antibiotics (10), but with NSAID’s (2) and allopurinol (1)
NORAM (cyclophosphamide vs methotrexate for induction of remis- also implicated. Two cases were associated with azithromycin which
sion in early Wegener’s granulomatosis), has recruited 55/90 patients. has only been reported in one previous case. Causes or associations
SOLUTION, an open study of anti-thymocyte globulin for refractory in the remainder were: Tubulointerstitial Nephritis and Uveitis (TINU)
AASV, has recently commenced. Standardised analysis of renal pathol- syndrome (2); tuberculosis (4); sarcoidosis (1); and MPO-ANCA posi-
ogy, correlating appearances with diagnosis, ANCA specificity, renal tive vasculitis (1). In two cases no specific aetiological agent could be
function and response to therapy, is underway. Further European implicated. Interestingly, we found that renal biopsy was not useful
Union funding has allowed the group to commence a second wave of prognostically. The patient with the most severe tubular atrophy re-
randomised clinical trials, comprising: CYCLOPS (continuous oral gained normal renal function, whereas two patients with only mild
vs pulsed cyclophosphamide for new patients with generalised/renal tubular dropout did not recover function. A total of fourteen patients
disease, creatinine , 500 mmol/l), REMAIN (low dose prednisolone/ received high dose oral steroids after presentation. Although statistical
azathioprine vs treatment withdrawal in long-term management), and analysis was not possible, due to small numbers, there was a tendency
MUPIBAC (effect of nasal Mupirocin on relapse in long-term therapy towards a more rapid fall in serum creatinine in steroid-treated cases.
of Wegener’s granulomatosis with good renal function). Multicentre In conclusion we find that the aetiology of ATIN is diverse, and thatethics applications have been submitted. The EUVAS group represents clinical features are non-specific. A renal biopsy is therefore essential15 European countries, and over 90 centres have entered patients. The for the diagnosis of ATIN, but will only provide limited prognostic14 participating centres in the UK have made an important contribu- information. In the absence of any controlled trial data we would stilltion, accounting for approximately 30% of patients entered to date. recommend a short trial of steroids.37 others have expressed interest and involvement of new centres in
MEPEX, NORAM, CYCLOPS, REMAIN and MUPIBAC is wel-
comed. Continuing expansion of the EUVAS trials will facilitate rapid
Serum Cystatin C measurement identifies men at high risk of renalanswers to important questions in the treatment of AASV, and will
damage due to benign prostatic hypertrophy. D.J. Newman, O.M.A.enhance the framework for future testing of innovative immunomodu-
Karim*, H. Thakkar*, Z. Ahsan*, A.M.I. Paris*, C.G. Fowler*, andlatory and anti-inflammatory therapies.
D.F. Badenoch*, S.W. Thames Institute for Renal Research, St. Helier
NHS Trust, Surrey and St. Bartholomew’s & The Royal London, Lon-
don, UK.* Benign prostatic hypertrophy is an almost universal findingDoes ANCA negative vasculitis differ from ANCA positive? A ten
in men over 50 years of age. Surgical treatment is the commonestyear retrospective study in Wessex. N.A. Hedger1, J.M. Stevens, N.
operation performed on men and hence, a major drain on health serviceDrey2, and P. Roderick, 1Wessex Renal and Transplant Unit, Ports-
resources. Prostatic hypertrophy can result in bladder outflow andmouth, 2The Wessex Institute for Health Research and Development,
upper urinary tract obstruction which if prolonged can cause renalSouthampton, UK. Between 1 April 1986 and 31 March 1996, 143 cases
impairment. Identifying those patients at most immediate risk of devel-of biopsy proven pauci-immune Rapidly Progressive Glomerulonephri-
oping chronic renal failure would aid in prioritising patients requiringtis (RPGN) consistent with a vasculitic illness were seen in the Wessex
prostatectomy and would reduce the proportion of patients that wouldRegion. The records of 128 of these were reviewed. Follow up (median,
develop end-stage renal failure with those additional personal andrange) was 1.8 (0–9.6) years from diagnosis. ANCA1ve cases were
health related costs. 16 men who presented with BPH and acute urinarycompared with ANCA2ve. The incidence of 3.5 per Million was stable
retention requiring decompression with emergency catheterization hadthroughout. The male female ratio was 1.3:1. Diagnosis was made
serum samples taken and GFR measurements performed within 24(median, 25th, 75th centile) 79 (46,166) days after symptom onset. Refer-
hours of initial catheterization. GFR was measured using plasma clear-ral delay (median, range) from other hospitals was 3 (0–41) days. Co-
ance of iohexol and creatinine and cystatin C were measured in themorbidity (mostly hypertension) was seen in 47%. Other organs affected
serum samples. The study group could be divided into three parts onwere; airways (lower 63%, upper 50%), joints 42%, muscle 33%, skin
the basis of their GFR and creatinine measurements. GFR (ml/min/22%, gut 24%, nerves 14%. Crescents (mean 6 SD) 54 6 26% were
1.73m2), creatinine (mmol/L), cystatin C (mg/L) were respectivelyseen in 96% of renal biopsies. Creatinine concentration (mean 6 SD)
(mean 6 SD) for Group A (n 5 8) 98 6 14, 105 6 11, 0.88 6 0.11,at diagnosis was 805 6 540 mmol/l. 73% were ANCA1ve (cANCA
Group B (n 5 4) 49 6 15, 105 6 13, 1.66 6 0.30, Group C (n 5 4)36%, PANCA 26%, undifferentiated 11%), 27% were ANCA2ve.
38 6 19, 217 6 126, 2.36 6 1.59. Using ANOVA analysis cystatin CApart from earlier diagnosis (P 5 0.02), less co-morbidity (p 5 0.03)
concentrations were significantly elevated (P , 0.05) in Group B andand fewer upper airway symptoms (P , 0.05), ANCA2ve cases were
C whereas creatinine was only significantly elevated in Group C. Thusvirtually identical to ANCA1ve. Treatment included established im-
men presenting with urinary retention may have a decreased GFRmunosuppressive regimens. 59% needed acute dialysis (D). Survival
despite a normal serum creatinine (50%). However serum cystatinwas 68% at one year, 29% requiring D, providing 2–3 new cases per
C measurement identified all patients with a decreased GFR (100%year for chronic D. Age was the main predictor of survival. Complica-
sensitivity). Thus cystatin C measurement could offer a sensitive meanstions were: infection 36%, neutropaenia 34% and recurrence 11%. 13
of screening patients with BPH to identify those at risk of renal impair-(10%) were transplanted with no recurrence. Graft survival was 92%
ment and who might benefit from early transurethral resection toat 1 year. This study has established the incidence and outcome of
ANCA positive and ANCA negative RPGN in a large, stable, affluent remove the hypertrophic prostate gland. Such prioritisation could re-
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duce the incidence of renal failure in this group of patients with signifi- Renal allograft rejection in patients receiving FK506 as primary immu-
cant benefits to the patient and reduction in health costs. nosuppressive therapy. R. Preston, S. Ball, T. Cairns, J. Contis, N.
Hakim, A. Palmer, V. Papalois, and D. Taube, Renal Unit, St. Mary’s
Hospital, London W2 1NY. The multicentre trials comparing FK506
Prevalence, predictors and prognostic significance of non-diabetic renal with Cyclosporin A in renal transplantation have demonstrated a re-
disease (NDRD) in patients with type II diabetes mellitus (NIDM). duced incidence and severity of acute rejection [AR]. The purpose of
A. Majumdar, K. Eardley, A.J. Howie1, C.O.S. Savage, D.C. Wheeler, this single centre study was to examine the incidence, nature and
N.T. Richards, D. Adu, and G.W. Lipkin, Departments of Nephrology outcome of AR in 104 consecutive patients [64M, 40F, mean age
and Pathology1, Queen Elizabeth Hospital, Birmingham. The preva- 42.9 yrs] receiving FK506 [mean dose 0.14 mg/kg/day], followed for a
lence, predictive factors and significance of NDRD in patients with minimum of 3 months [mean 20 months]. AR was always diagnosed
NIDM remains unclear. In a prospective study patients with NIDM by biopsy and classified for the purpose of this study as cellular or
referred with renal disease between 1991 and 1993 underwent renal vascular. Overall patient survival was 99% [1 yr] and 97.1% [2 yrs]
biopsy. Out of 82 patients, 56 (68%) had diabetic glomerulonephropa- with graft survival of 94.2% [1 yr] and 91.3% [2 yrs]. There were 3
thy (DGN), of whom 6 (7%) had an additional renal disease. Twenty deaths with functioning grafts [2 sepsis, 1 breast carcinoma] and 6
six (32%) had NDRD. Advanced diabetic retinopathy (ADR) was further graft losses [4 technical failures and 2 non-compliant patients].
present in 54% of patients with DGN as compared to 8% in patients 36 patients [33.4%] experienced 47 discrete episodes of AR [35 cellular,
with NDRD alone (P , 0.01). Of patients with ADR, 94% had DGN. 12 vascular]. Cellular rejection was treated with methyl prednisolone
Clinical management was altered by the knowledge of renal pathology [MP]; 5 patients received Mycophenolate Mofetil [MMF] in addition.
in 60% of those with NDRD and in 23% of the group as a whole. Vascular rejection was treated with MP, ATG/ALG [9 patients] and
Between 1995 and mid 1998, 174 patients with NIDM and renal disease MMF [8 patients]. All AR episodes were successfully reversed although
but without ADR underwent renal biopsy. Eighty seven (50%) had the plasma creatinine in 16/36 patients [44%] did not return to pre
NDRD and clinical management was altered by knowledge of renal AR levels, including 9 of the patients with vascular rejection. The 2
histology in 45% of cases. Complete 5 year follow up was available patient deaths with sepsis followed treatment of AR which included
on the original 1991–1993 82 patient cohort. MMF. This study demonstrates a low incidence of AR in patients
treated with FK506 as primary therapy. Although vascular rejection
did not result in graft loss, function did not return to baseline. The
DGN NDRD P value combination of FK506 and MMF has been associated with 2 deaths
from sepsis and must therefore be viewed with caution.Mortality% 52 54 NS
ESRF % 54 23 ,0.01
Evaluating the patterns of ANCA reactivity in HL60 cells induced to
differentiate by retinoic acids and azacytidine. S.M. Zahed Chowd-Death/ESRF was more common in those with ADR (72 vs. 36%, P , hury1,2, G.P. Spickett1, R. Wilkinson2, and V. Broomhead1, Regional0.01), neuropathy or hypertension at presentation. Immunology Laboratory1, Royal Victoria Infirmary and Dept. of RenalFrom the 1991–93 and 1995–98 studies we conclude that renal biopsy Medicine2, Freeman Hospital, Newcastle upon Tyne, UK. Antineutro-is an appropriate investigation in patients with renal disease and NIDM phil cytoplasmic antibodies (ANCA) are important diagnostic andwithout evidence of ADR and leads to a change in management. The prognostic markers for systemic vasculitides including Wegener’s gran-follow up study shows that renal survival in patients with DGN is ulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and idio-inferior to those with NDRD. In this patient group mortality is high
pathic necrotising crescentic glomerulonephritis. The standard methodand is unaffected by renal pathological findings but is greater in those
for ANCA detection is indirect immunofluorescence (IIF) on ethanolwith ADR.
fixed human neutrophils. Cytoplasmic (C-ANCA) and perinuclear (P-
ANCA) staining patterns are commonly associated with proteinase-3
(PR-3) and myeloperoxidase (MPO) antigens of human neutrophilsPost-transplant HLA specific antibody production in tacrolimus mo-
respectively. C-ANCA is more common in Wegener’s granulomatosisnotherapy treated renal transplant recipients. A. Langton1, J.E. Wor-
while P-ANCA is associated with wide variety of conditions includingthington1, S. Martin1, P.A. Dyer1, R.W.G. Johnson2, and C.D. Short3,
microscopic polyangiitis and idiopathic crescentic glomerulonephritis.Transplantation Laboratory1, Renal Transplant Unit2, and Dept. of Re-
It has been suggested earlier that promyelocytic cell line HL60 isnal Medicine3, Manchester Royal Infirmary, Manchester, UK. It is recog-
suitable for investigating ANCA. HL60 cell line have been used pre-nised that renal transplant recipients who subsequently develop donor
viously as myeloid differentiation model. In this study we investigatedHLA specific antibodies experience less favourable graft survival. We
the ANCA reactivity of HL60 cells induced by several differentiatinghave investigated antibody production, using ELISA and flow cytome-
agents (all trans, 13-cis, 9-cis retinoic acid and azacytidine). HL60 cellstry techniques, in two groups of patients treated with either tacrolimus
are subcultured and incubated with differentiating agents at different(Tac, n 5 28) as the sole immunosuppressive agent or a cyclosporin
concentrations (1026 M to 1028 M/l) and incubated for variable timebased regimen (CsA, n 5 28). Both groups had received crossmatch
period (3–6 days) and then cytocentrifuged and ethanol fixed andnegative primary renal transplants in 1996 and were matched for gender
stored at 2208C. Sera with known IIF pattern on ethanol fixed humanand pre-transplant antibody status. The mean number of HLA mis-
neutrophils and antigen specificity (PR-3 and MPO) including ANAmatches was 1.86 in each group. Forty six of the patients were antibody
positive (on HEp-2 cells) and ANCA negative sera were tested repeat-negative both pre-and post-transplantation and were not investigated
edly against differentiated ethanol fixed HL60 cells. It is observed thatfurther. Five patients (2 Tac and 3 CsA) were antibody positive pre-
induced HL60 cells show enhanced reactivity with C-ANCA (bothand post-transplant but only 1, from the CsA group and prior to
PR-3 positive and negative) and P-ANCA (MPO positive) as comparedtransplant failure, had developed additional antibodies against donor
to HL60 cells without any differentiating agents. Non-MPO-P-ANCAmismatched HLA antigens. There was a decrease in the reaction fre-
and negative sera (negative for ANCA by IIF and ELISA) do notquency, as determined by ELISA, for 2 of the Tac treated patients
show any positive fluorescence. Patterns of reaction between C-ANCAfrom 65.9% and 48% to 24.4% and 24%, respectively. Five patients,
and P-ANCA are not distinctly clear even using fluorescence confocal1 Tac and 4 CsA, who were antibody negative pre-transplantation,
microscopy. There are morphological changes in the differentiatedsubsequently became positive, although in 2 of the CsA patients this
cells (cells are smaller with increased indentations in the nuclei andrelated to a sensitization event prior to transplantation. In 3 male
amount of cytoplasm also increased). There are no significant differ-patients (1 Tac and 2 CsA) with no history of potential sensitising
ence between different agents in improving ANCA reactivity. It canevents, IgM HLA specific antibodies were detectable for the first time
be concluded that differentiated HL60 cells show enhanced ANCAfollowing transplantation. In summary, only 1 patient (3.6%) treated
reactivity with positive sera but patterns between C-ANCA andwith Tac monotherapy developed HLA specific antibodies following
P-ANCA are not reliably differentiated. Non MPO-P-ANCA antigensrenal transplantation compared with 5 patients (18%) who received a
are not well expressed even in differentiated HL60 cells. Using differen-CsA based immunosuppressive regimen. These preliminary data sug-
tiated HL60 cells for ANCA screening followed by specific ELISAgest that the use of tacrolimus may limit the production of HLA specific
(PR-3 and MPO) might be alternate strategy of ANCA detection inantibodies following transplantation and that the observation warrants
further study. routine clinical setting.
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C1q deficient mice develop severe disease in accelerated nephrotoxic meeting the following criteria: diagnosis within the spectrum of AASV;
biopsy-proven necrotising and/or crescentic glomerulonephritis; creati-nephritis. M.G. Robson1, H.T. Cook2, M. Botto1, C.D. Pusey3, M.J.
Walport1, and K.A. Davies1, Rheumatology Section1, Department of nine .500 mmol/l or dialysis-requiring; treatment with oral steroids,
oral cyclophosphamide and at least 5 plasma exchanges; maximum ofHistopathology2, and Renal Section3, Imperial College School of Medi-
cine, Hammersmith Hospital, Du Cane Road, London. The comple- 1 pulse of methylprednisolone. Follow-up data were available in 73
patients. The median age was 60. Clinical diagnoses were Wegener’sment system is thought to play a role in inflammatory tissue injury by
a variety of mechanisms. However, the development of autoimmune granulomatosis (33), microscopic polyangiitis (22), renal-limited vascu-
litis (16), and Churg-Strauss syndrome (2). All patients tested weredisease in humans deficient in classical pathway components suggests
that complement may also have a protective role. Accelerated nephro- ANCA-positive. 55/73 required dialysis at presentation; median creati-
nine in the remainder was 628 mmol/l. Six patients were ventilated fortoxic nephritis is a model of progressive renal disease that develops
in response to a foreign antigen planted in the glomerulus. We investi- lung haemorrhage. At 2 months, 54 (74%) were alive with independent,
improved renal function; 12 (16%) were dialysis-dependent and 7gated the role of complement in this model. C1q deficient mice were
generated by gene targeting. Nephrotoxic IgG was prepared by im- (10%) were dead. Actuarial survivals in the 54 responders were:
munising rabbits with a mouse glomerular preparation and ammonium
sulphate precipitation of the serum. Mice of mixed genetic background
(C57BL/6 3 129/SV) were immunised with 200 mg of rabbit IgG in 1 year 5 years 10 years
Freund’s complete adjuvant intraperitoneally. Seven days later they
Patient survival 88% 71% 60%were given 1 mg of nephrotoxic IgG intravenously. This dose did not
Renal survival 98% 83% 56%cause a significant heterologous phase when given to non-immune
mice. Ten wildtype (WT) mice and ten C1q deficient (C1qa2/2) mice
were studied. Four days after injection of nephrotoxic IgG the C1q
deficient mice became unwell whereas all of the wildtype mice re- Renal recovery was maintained long-term in the majority. Progression
mained healthy. The mice were sacrificed and histology showed severe to endstage renal failure was seen in 8/9 patients with recurrent nephri-
glomerular thrombosis in all the animals in the C1qa2/2 group. Only tis and in 8 patients with significant renal impairment after treatment
mild proliferative changes were seen in the WT group. Serum creatinine (median 2-month creatinine 326 mmol/l). 21 patients died during follow-
was higher in the C1qa2/2 group (median 66 mmol/l) compared to up, from a variety of causes; median age at death was 75. We conclude
WT (median 42 mmol/l, P , 0.0001, U 5 1). Serum albumin was lower that salvage of renal function may be achieved using an intensive
in the C1qa2/2 group (median 14 g/l) compared to WT (median 23 regimen containing plasma exchange in many patients with severe
g/l, P 5 0.0037, U 5 7). The data suggest that C1q may have a role glomerulonephritis due to AASV; this benefit is longlasting.
in preventing immune-mediated glomerular disease.
Relationship of proteinuria to renal dysfunction in patients with athero-
Clinical presentation and diagnostic delays in Wegener’s Granulomato- sclerotic renovascular disease. A.D. Makanjuola1, M. Suresh2, P. Laboi2,
sis: a questionnaire based survey. P. Cockwell, C. Day, K.E. Eardley, P.A. Kalra2, and J.E. Scoble1, Renal units of Guy’s Hospital, London1
and C.O.S. Savage, Department of Nephrology, Queen Elizabeth Medi- and Hope Hospital, Salford 2, U.K. Proteinuria is well described in
cal Centre, Birmingham. Wegener’s Granulomatosis (WG) is a primary atherosclerotic renovascular disease (ARVD), but the prevalence is
small vessel vasculitis with multi-organ involvement. Delays in diagno- unknown, and the pathogenesis may vary between patients. Substantial
sis are frequent and may lead to increased morbidity. We distributed proteinuria (.2 g/day) however, would be regarded by many as atypical
a national questionnaire based survey via the Stewart Strange Trust for ARVD. We performed a prospective study that involved two renal
to patients with known WG to assess presenting symptoms, initial centres so as to ascertain the pattern and extent of proteinuria in
investigations, diagnostic delays and renal outcome. A total of 104 92 patients with angiographically proven renovascular disease and to
patients replied, 68 female and 36 male. Median age (range) at presen- observe any correlation with renal dysfunction. Protein was assayed
tation was 49 years (18–78) and median length of illness at first consulta- in 24 hr urine collections and the GFR was derived using the Cockroft-
tion with a GP was 21 days (1–1460). At presentation 74% of patients Gault formula. Male (51) to Female ratio was 1.24:1, and the median
had ENT symptoms, 56.7% arthralgia, 40.4% dyspnoea, 37.5% weight age was 67 years (range 49–87). 39/92 (42%) had proteinuria less than
loss and 30.8% a rash. 65.4% had symptoms attributable to two or 0.5 g/24h. In the following chart, mean proteinuria is plotted against
more organ systems. At the first or subsequent GP review urinalysis ranges of GFR.
was performed on 12.5% and blood tests on 41.3% of patients. Median
time between GP consultation and review by a hospital specialist was
42 days (1–1460). The presence of multiple symptoms or performance
of urinalysis or blood tests did not predict early referral. At hospital
review urinalysis was performed on 69% of patients and predicted
early diagnosis; in tested patients median time to diagnosis was 14
days (1–1501) and in untested patients 50 days (1–1100) (P 5 0.0052).
13.4% of patients required dialysis, 3.8% of patients are still dialysis
dependent and 4.8% have a functioning transplant. In patients requir-
ing dialysis there were no additional delays in diagnosis. In conclusion;
(i) although patients with WG usually present to a GP with multi-
organ symptoms urinalysis is infrequently performed, (ii) multi-organ
symptoms or urinalysis does not predict early referral to hospital and
(iii) although hospital urinalysis predicts early diagnosis, in a substantial
proportion of patients this test is not performed.
Long-term outcome after plasma exchange and immunosuppression
for severe vasculitis-associated glomerulonephritis. G. Gaskin, and The data illustrate that in contrast to other renal diseases, proteinuria
C.D. Pusey, Renal Section, Division of Medicine, ICSM, Hammersmith actually increases with worsening renal function in patients with
Hospital, London, UK. The long-term outcome of patients treated for ARVD. Biopsies were performed on 6 patients with substantial pro-
severe glomerulonephritis in ANCA-associated vasculitis (AASV) is teinuria. Histology showed minimal change disease (1); glomerular
uncertain: Hogan et al (JASN 1996) suggest that endstage renal failure sclerosis with marked ischaemic changes (2); and focal glomeruoscle-
is delayed by immunosuppression but not prevented. Furthermore, rosis (3) respectively. These are all recognised features of atheroscle-
the value of plasma exchange is debated. We therefore performed a rotic nephropathy. We would therefore suggest that proteinuria, rather
than being indicative of some other pathology as previously thought,retrospective analysis of 74 consecutive patients treated at our unit
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is more a marker of severity of parenchymal disease i.e. atherosclerotic R.G. Jones, P. Hamden, L.D. Hordon, A.M. Brownjohn, and J.H.
Turey, Renal Unit, Institute of Pathology, Leeds General Infirmary andnephropathy, which itself is the major determinant of renal dysfunction
in these patients. Department of Human Biology, University of Leeds, Yorkshire, UK.
Intermittent dosing of vitamin D by either an oral or intravenous route
may be successful in controlling hyperparathyroidism in those patients
who are hypercalcaemic with a daily oral regime. We have shown inAn investigation into the methods of identification of renal artery
a previous study that bone alkaline phosphatase (BAP) is a morestenosis. S. Carr1, R. Sayers2, A. Lynham1, D. Wilcox3, Y. Rees4, K.
accurate marker than total alkaline phosphatase (TAP) for the diagno-Mulchay4, Department of Nephrology1, Department of Surgery, Leices-
sis of hyperparathyroid renal oesteodystrophy. This study investigatedter General Hospital 2, Department of Radiology, University of Leices-
whether BAP was a more accurate marker than TAP for monitoringter3, Leicester General Hospital4, U.K. Atheromatous renal artery steno-
changes in bone turnover in the treatment of hyperparathyroid renalsis (RAS) is an important cause of hypertension, renal impairment
osteodystrophy. Seventeen hyperparathyroid dialysis patients (11 male,and end stage renal failure (ESRD). Studies have reported that approx-
6 female) completed 9 months treatment with pulsed oral calcitriol (0.5–1imately 15–20% of patients with ESRD have RAS and at the present
mcg thrice weekly). All patients underwent an iliac crest bone biopsytime this condition is almost certainly underdiagnosed. There are nu-
prior to treatment; 9 patients were identified as having a moderate andmerous techniques available for the investigation of RAS but at present
8 severe hyperparathyroidism. A further bone biopsy was performedarteriography remains the “gold standard.” Arteriography is relatively
after 6 months treatment. Calcium carbonate was used as the principalexpensive and carries a small but appreciable risk. The aim of this
phosphate binder. The dose of calcitriol and calcium carbonate werestudy was to compare colour duplex ultrasonography (US), spiral CT
adjusted to keep the serum standard calcium ,2.8 mmol/L and phos-scanning (CT) and magnetic resonance imaging (MRA) in the detection
phate , 2.0 mmol/L. BAP, TAP and iPTH were measured monthly.of RAS using arteriography as the “gold standard”. Patients were
Results 6 SD for the 12 patients who responded to treatment arerecruited when referred for renal arteriography, diabetics and subjects
shown below. Statistical analysis paired T test (*P , 0.05, **P , 0.01).with serum creatinine greater than 400 ug/ml were excluded. Fifteen
patients (9 male) have been studied (36 renal arteries) with mean age
64 SD 7.4 years, GFR 37 ml/min/1.73 m2 SD 22, 24 hour urinary protein
0.91 g SD 0.9, systolic blood pressure 146 mmHg SD 23, diastolic blood Pre 3/12 6/12 9/12
pressure 82 mmHg SD 11. Results refer to the detection of stenoses
Ca mmol /l 2.4760.12 2.58 60.17 2.58 60.21 2.65 60.19**.50% of vessel diameter.
PO4 mmol /l 1.9760.43 1.9 60.39 2.0 60.32 2.0360.63
iPTH pg/ml 5636560 443 6479* 410 6318* 307 6305*
ALP IU/l 2686142 251 6135 202 67.0* 204 686*
Sensitivity Specificity Positive predictive Negative BAP ng/ml 18.3615.44 16.9 611.3 15.1 68.3 10 64.4*
% % value % predictive value %
US 66.7 84.2 57.1 88.9
CT 87.5 95 87.5 95 Twelve of the 17 patients responded to treatment. Bone biopsies after
MRA 100 61.5 64.3 100 6 months treatment showed histological evidence of improvement in
these 12 patients, with 2 biopsies revealing adynamic bone disease. In
the 12 patients who responded, there was a significant reduction in
both BAP and TAP. There was no significant reduction in iPTH,MRA had highest sensitivity but a high false positive rate, Spiral CT
BAP, or TAP in the 5 patients who did not respond to treatment. Inhad a lower sensitivity but lower false positive rate. Duplex US had
conclusion, the measurement of BAP did not have any advantage overlower sensitivity and specificity.
TAP in the monitoring of the treatment of hyperparathyroid renal
osteodystrophy.
Renal artery revascularisation as a treatment for intractable cardiac
failure. C. Killeen, P. Sweny, and T. Watkinson, Departments of Renal
The influence of cyclosporin on IL-8 production by human osteoblast-Medicine and Radiology, Royal Free Hospital, London, NW3 2GQ.
like cells in vitro.. Th Apostolou1, M.L. Picton1, W. Staley2, R. Byers2,We assessed the cardiovascular response to renal artery (RA) revascu-
larisation in patients with RA stenosis and congestive cardiac failure B.M. Coupes1, P.A. Brenchley1, A.J. Hutchison1, R. Gokal1, and J.A.
(CCF) unresponsive to medical management. Eight patients were iden- Hoyland2, Renal Research Group1, Manchester Royal Infirmary, Man-
tified with refractory CCF and significant RA stenosis (.75%), 7 chester and Musculoskeletal Research Group2, University of Manchester,
bilateral, 1 unilateral. All patients presented with acute renal failure UK. Many investigators have found cyclosporin to have an effect on
after starting angiotensin converting enzyme inhibitors (ACEI) for bone metabolism. In humans treated with cyclosporin there appears to
management of their CCF. 7 patients had a positive captopril isotope be an imbalance between bone formation and resorption. Osteoblasts
renography. Degree of RA stenosis was confirmed on angiography. produce a range of factors which are believed to play a crucial role
All patients underwent RA angioplasty or stenting. Cardiovascular in the regulation of these processes. Of these factors IL-8 is thought
response to revascularisation was assessed by measuring exercise toler- to recruit osteoclasts into bone, therefore an increase in IL-8 production
ance, changes on echocardiography, changes in diuretic requirement by osteoblasts may increase osteoclast recruitment. SaOS-2 cells are
and changes in weight (volume status). All patients showed significant known to produce IL-8 in vitro. SaOS-2 cells were cultured in (aMEM
improvement in exercise tolerance, New York Heart Assoc. (NYHA) with 5% FCS in and allowed to reach confluence. At this point medium
grade III/IV pre and NYHA grade I/II post revascularisation. 3/4 of was introduced which contained Cyclosporin A at 10,000 pg/ml, 1,000
patients had an increase in cardiac ejection fraction. All patients pg/ml, 100 pg/ml and control medium with and without ethanol carrier.
showed a significant reduction in diuretic requirement (mean 75% Cells were exposed to these various culture conditions for 24 and 48
decrease), with an average decrease in body weight of 7.4 kilos. 3/4 hours. At these time-points the medium was removed and the amount
of patients recommenced ACEI two weeks to four months following of IL-8 assayed using an ELISA method. Cell number was measured
revascularisation. There was no deterioration in renal function on at both time-points using an electronic cell counter. At 24 hours no
follow up. Mean duration of follow up 16.2 months. RA stenosis needs significant difference in the amount of IL-8 was detected in the various
to be actively looked for in patients presenting with refractory CCF. culture conditions. However at 48 hours there was a significant increase
Revascularisation caused a significant improvement in exercise toler- in IL-8 concentration in the presence of Cyclosporin at all three concen-
ance, quality of life and enabled the reintroduction of ACEI. trations. So that medium with Cyclosporin A at 10,000 pg/ml, 1,000
pg/ml, 100 pg/ml and control medium with and without the ethanol
carrier were associated with IL-8 concentrations of 109 (pg/ml), 106
(pg/ml), 94 (pg/ml), 79 (pg/ml) and 75 (pg/ml) respectively. There wasAssessment of bone alkaline phosphatase in the treatment of hyperpar-
athyroid renal osteodystrophy with pulsed oral Calcitriol. S. Fletcher, no significant difference in cell number at either time-point. Therefore,
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Cyclosporin A at concentrations encountered in clinical practice is tients immediately prior to treatment, during the 24 hour period encom-
passing the last infusion, and 3 months later. Serum samples wereassociated with increased IL-8 production by human osteoblast-like
cells cultured in vitro. Further work will aim to examine the effect of taken on completion of the collections. Data from 28 patients were
analysed: (Aged: 49–90 yrs, mean 74 yrs; 3M:25F; pretreatment clear-cyclosporin on the production of IL-8 by primary human bone cells
in vitro. ances:—adjusted to 1.73 m2—25–49 mls/min, mean 40 mls/min.) The
results were analysed by the Wilcoxon matched-pairs signed-ranks test,
but paired t-tests produced similar results. Comparison of pretreatment
with end-of-treatment results showed no significant changes in creati-Bone remodelling after renal transplantation: an index of latent hyper-
parathyroid bone disease. R. Rustom, A.K. Shanna, R.A. Sells, and J.M. nine clearance, alanine aminotransferase (ALT) or aspartate amino-
transferase (AST). However at 3 months, creatinine clearances showedBone, Regional Renal Transplant Units, Royal Liverpool University
Hospital, Liverpool, UK. Hyperparathroidism (HPT) is still a major a significant tendency to increase (mean 40 Vs 52 mls/min, P , 0.001),
as did AST (mean 18 Vs 20 U/l). ALT fell slightly with the infusionproblem in patients with end stage renal failure even after transplanta-
tion (Tx) despite the use of active vitamin D metabolites over twenty but then showed a significant tendency to increase (P 5 0.012), but 3
month values were not significantly different from pretreatment valuesyears. Unfortunately, parathyroid hormone assays (PTH) over this
period have been either not available routinely or have changed over (P 5 0.211). So far this shorter regimen has not yielded any significant
adverse consequences in renally impaired patients.the years. C-terminal assay detect not only active PTH, but also active
fragments which are retained in renal failure. More recent assays detect
the intact active PTH molecule. This makes it difficult to analyse and
compare long term therapeutic strategies. It would thus be helpful to Albumin as an outcome measure in haemodialysis patients: the effect
of variation in assay method. A. Carfray1, K. Patel1,2, P. Whittaker2, P.have a separate index of HPT applicable to all patients. In this study
we examine the usefulness of the rise and fall of the plasma alkaline Garrick2, G. Griffiths3, and G. Warwick1, Dept. of Nephrology, Leicester
General Hospital1, Leicestershire Pathology Service, Leicester Royalphosphatase of bone origin (ALP) after Tx for this role. In our centre
PTH levels were available routinely after 1985, sensitive to the C Infirmary2 and Dept. of Pathology, Lincoln County Hospital, Lincoln3.
Serum albumin is an important predictor of future mortality/morbidityterminal until 1992, and to the intact molecule thereafter. Between
1975 and 1995, 9 Tx patients needed parathyroidectomy (PTX) and in patients with renal failure and has become an important audit mea-
sure. The RA standards document recommends that serum albumin38 patients had bone pain after Tx. All these patients showed a rise
in ALP over many months, as well as raised PTH levels. Additionally, should be ‘within the normal range quoted by the local pathology
laboratory’ in recognition that different methods of measuring albuminthere was also a large group of asymptomatic patients who showed a
post Tx rise in ALP, with high PTH levels. The table shows that patients give different results. We have assessed three different methods for
albumin measurement i.e. dye-binding methods with bromocresolwith symptomatic HPT had the highest rise in ALP, and the highest
PTH levels. In an unselected group of 97 asymptomatic patients, be- green (BCG) and bromocresol purple (BCP) and an immunoturbidi-
metric method to determine the percentage of patients within thetween 1985 and 1995, 46 had a rise in ALP with similar PTH levels
to those with bone pain. By contrast, 41 patients with no ALP rise normal range with each assay and to measure any systematic bias with
either dye-binding method. Routine samples were collected from 146had the lowest PTH levels. Patients with cyclosporin toxicity were
excluded from the analysis. haemodialysis (HD) patients and 50 anonymous controls. Using the
BCG method, 87% of HD patients and 84% of controls had values
within the normal range (35–52 g/L). However, with the BCP method
only 57% of HD patients were within normal range (35–55 g/L) whileALP U/L PTH*
the % for controls was unchanged (84%). The average differences (bias)
Duration C-terminal and the 95% limits of agreement between the dye-binding methods and
Peak month U/L Intact pmol/l the immunoturbidimetric method are shown in table (units 5 g/L):
Symptomatic
PTX (9) 680 6 163 18.7 6 4.0 535 (280–1000) 142 (132–151)
BCP method BCG methodBone pain (38) 409 6 75 26.4 6 6.2 194 (72–735) 20.8 (12–41)
Asymptomatic Bias 95% limits Bias 95% limits
ALP rise (46) 310 6 44 15.1 6 2.3 159 (68–1000) 18.2 (10–157)
No ALP rise (41) — — 91 (40–696) 7.5 (1–108) All subjects 1.8 22.3; 15.9 4.4 20.9; 19.7
HD 1.2 22.6; 14.9 4.8 20.2; 19.8* Geometric mean
Control 3.6 10.8; 16.4 3.2 22.1; 18.5
Albumin ,35 g/L 1.2 22.9; 15.3 5.7 11.1; 110.3
Albumin .35 g/L 2.1 21.9; 16.1 3.6 21.3; 18.4These data suggest that the rise in ALP after Tx could well reflect the
prior control of hyperparathyroid bone disease.
Differences in concentrations were plotted against the average value
for each pair of methods (BMJ 1995;346:1085–7). BCG over-estimatedEarly renal and hepatic safety data for a shorter intravenous clodronate
regimen in renal impairment. D. de Takats, K. Pande, E.V. McCloskey, albumin compared to the other methods and the magnitude was in-
versely related to albumin concentration (up to as much as 10 g/LV. Edwards, and J.A. Kanis, The (WHO Collaborating) Centre for
Metabolic Bone Diseases at Sheffield, Royal Hallamshire Hospital, difference). Although BCP gave slightly higher concentrations than
the immunoturbidimetric method particularly in controls, there wasGlossop Road, Sheffield, S10 2JF. Clodronate (dichloromethylene bis-
phosphonate), a specific inhibitor of osteoclast-mediated bone resorp- no variation over the range of albumin concentrations. We conclude
that the method of albumin assay has a major influence on results intion used for the treatment of osteoporosis and Paget’s disease, is
cleared unchanged in the urine. When given in high doses to animals haemodialysis patients. Comparative audit is difficult where nephrol-
ogy departments may be served by different laboratories using differentit causes acute tubular necrosis and hepatitis; in patients oral clodronate
can raise transaminases. Use of intravenous regimens in renally im- methods. Standardisation of albumin assay using the more accurate
BCP method would solve these problems.paired patients might cause tubular damage due to high local concentra-
tions, and the slower clearance exposing the liver to higher concentra-
tions for longer periods might cause important hepatitis. We have
previously investigated the effects of a 5 day 3 300 mg intravenous Tunnelled (cuffed) haemodialysis catheters: a questionnaire survey of
policies and outcomes in the U.K. M.J. Kumwenda and F.K. Wright,clodronate regimen on creatinine clearance in patients with renal im-
pairment and not found any deleterious effects. To reduce hospital Glan Clwyd Distyict General Hospital, Bodelwyddan, Denbighshire,
LL18 5UJ. Haemodialysis via tunnelled catheters has been adoptedstay a shorter regimen is desirable, provided it is safe, so a 3 day
intravenous clodronate regimen (300 mg, 600 mg, 600 mg) was insti- worldwide for patients with end stage renal failure without viable
vascular access. We were interested to investigate the policies advo-tuted. We obtained 24 hour urine collections from all consenting pa-
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cated by different dialysis centres in the UK for these catheters and and URR before and after an increase in dialysis hours. Mean URR
rose from 41.6% to 51.8% (P 5 0.02), while mean PRR fell slightlythe management of catheter related complications. In 1996–1997 we
sent postal questionnaires to 68 nephrologists, 41 (60.3%) responded. from 31.8% to 25% (P 5 NS). Mean predialysis phosphate fell from
2.35 to 1.86 mmol/l. In conclusion, measurement of post dialysis phos-We ascertained the following a) Type of catheter: 32 centres (78.4%)
used Permcath, 3 centres Tesio, 3 Vascath, 3 Francis and in 8 centres phate gave little additional information. PRR was associated with pre-
dialysis phosphate levels, but did not seem to be a good indicator of.1 type of catheter was used b) Catheter insertion techniques: Physi-
cians used the Seldinger technique in 16 centres, surgeons “open” phosphate removal on dialysis, perhaps because of the kinetics of
phosphate mobilisation from extravascular compartments during dial-surgical technique in 10 and the rest used both techniques. Most centres
(64%) used the jugular route for primary cannulation and the others ysis. Whether PRR can be used to estimate phosphate absorption from
diet is not established, but seems unlikely. Increasing dialysis durationsubclavian. Only 30 centres used fluoroscopy and/or ultrasound to aid
catheter insertion c) Anticoagulation: nearly 80% of the centres primed seems an effective method for achieving adequate phosphate control
in haemodialysis patients.the catheters with 5000 units or less of heparin post dialysis and the
other centres used .5000 units, 4 used Warfarin routinely as prophy-
laxis d) Catheter complications: only 16 centres managed to collect
data for this prospectively over a 12 month period. 12 centres used The relevance of omission of antihypertensive medication to the 48
hour ambulatory blood pressure profiles of haemodialysis patients.urokinase to declot catheters, exit site infections and septicaernia were
treated empirically with intravenous vancomycin and flucloxacillin in M.J. Wright, K. Bel’eed, D. Eadington, M.J. Farr, and L. Sellars, Renal
Unit, Hull Royal Infirmary, Anlaby Road, Hull. Some patients omit12 centres, vancomycin with ciprofloxacin in 2 and vancomycin with
gentamicin in I centre. A total of 530 catheters were inserted and 148 their antihypertensive medication (AM) prior to haemodialysis in order
to ameliorate symptomatic hypotension during ultrafiltration. Compar-(28%) were removed due to catheter related complications. There
were 4 deaths, probably catheter related. We recommend the use of ison of pre- and post-dialysis BP is difficult in this situation. The effect
of omitting pre-dialysis AM on ambulatory BP monitoring (ABPM)fluoroscopy and/or real time ultrasound scan to aid all catheter inser-
tions and the use of 4-fluoroquinolones for empirical treatment of is not well described. We have studied 48 hr ABPM profiles in 25
stable haemodialysis patients: group 1 (6M: 3F, mean age 68y) tookcatheter related infections (vancomycin use should be minimised in
case of vancomycin resistant enterococci) and if signs of infection do not AM before dialysis; group 2 (5M: 1F, age 62 y) omitted AM before
dialysis; group 3 (6M: 4F, 73y) needed no AM. ABPM (Spacelabsresolve within 48 hours the catheter should be removed. Conclusion:
During this study period dialysis centres in the UK had clear policies 90207, every 30 min) was performed during the 48 h interdialytic (ID)
interval. Analysis was by ANOVA (repeated measures) and pairedrelating to tunnelled haemodialysis catheters. However, the manage-
ment and outcomes of catheter related complications should be re- t-tests. Pre-dialysis MAP exceeded mean ID MAP for groups 1 & 3 (110
mmHg vs 100 mmHg; P 5 0.04 and 105 vs 93; P 5 0.02 respectively), butcorded and audited. Catheter guidelines must be established.
not group 2 (105 vs 97; P 5 0.23). Post-dialysis MAP did not differ
from ID MAP in any group (group 1 110 vs 100; P 5 0.12: group 2,
95 vs 97; P 5 0.81: group 3, 95 vs 93; P 5 0.61: overall 101 vs 96; PIs automated peritoneal dialysis a superior form of peritoneal dialysis.
H.K.I. Anijeet, R. Rustom, P. Livesley, B.M. Bell, and R. Ahmad, 5 0.176). The overall profile did not differ between groups, but there
was deviation from the mean within each group (Table 1 shows signifi-Division of Nephrology, Royal Liverpool University Hospital, Liv-
erpool, United Kingdom. The cheapest patient is a fit and well treated cant time points for all groups combined) with a fall in MAP between
9 and 18 hours and a rise at 2, 24 and 42 hours.one even if the immediate cost appear to be higher. Automated Perito-
neal Dialysis (APD) at present is more expensive than Chronic Ambu-
latory Peritoneal Dialysis (CAPD). We submit our data over last two
years on the incidence of peritonitis in Liverpool comparing patients Time Mean MAP P value
receiving the disconnect CAPD system and APD in terms of the inci- post-dialysis h mm Hg (vs. overall ID MAP)
dence of peritonitis. The CAPD group contained 83 patients (42 male
0–2 101 ,0.001and 41 female) and APD group had 22 patients (13 male and 9 female).
6–9 93 0.014The total experience in the CAPD group was 783 patient months
9–12 92 0.013(mean 9.5 6 0.6, range 2–22) and in the APD group, 240 patient months
12–15 92 0.002(mean 12.3 6 1.7, range 2–24). There were 6 episodes of peritonitis
15–18 94 0.009in 5 patients belonging to APD group. In the CAPD group 28 episodes
21–24 99 0.047of peritonitis occurred in 20 patients. The peritonitis rate in CAPD
39–42 101 0.058group was one in 27.9 patient months and that in APD group was one
in 40 patient months (P , 0.001). Our data suggest that APD seems
to be superior to disconnect CAPD system in terms of the incidence
of peritonitis. The decrease in peritonitis rate is an important factor In summary, omission of AM pre-dialysis does not affect the ABPM
in the longevity and quality of life in patients on peritoneal dialysis. This profile. ID BP is lowest 9–18h post-dialysis. Post dialysis BP correlates
issue needs careful evaluation because of implications with purchasers. better with the ID BP than pre-dialysis BP, and is the more appropriate
measure in making judgements about antihypertensive medication.
Is phosphate reduction ration a useful test in haemodialysis patients?
S. Azher, S. Fletcher, A. Bakewell, and R.M. Higgins, Renal Unit, Cancer Antigen 125 does not reflect peritonea function in CAPD
Walsgrave Hospital, Coventry. Control of serum phosphate in haemodi- patients. A. Davenport, J. Allington, and G. McGreanor, Department
alysis is a clinical problem, despite the adjustment of dialysis dosage of Renal Medicine, Royal Free Hospital, London, NW3 2GQ. Cancer
by criteria such as urea reduction ratio (URR). We measured pre- antigen 125 (CA125) has been reported to reflect peritoneal mesothe-
and post-dialysis phosphate in 87 stable patients on thrice weekly lial cell mass, and to be related to peritoneal transport, with reduction
in CA125 reported to predict sclerosing peritonitis. We prospectivelyhaemodialysis in order to see if phosphate reduction ration (PRR)
might be useful. Blood was taken before and 15 minutes after dialysis, measured CA125 in the peritoneal dialysis effluent during 132 perito-
neal equilibration tests in 72 CAPD patients, mean age 57 yr (rangePRR was calculated as change in phosphate divided by predialysis
phosphate 3 100. Mean URR was 53.6% and mean PRR was 33%. 20–84), mean duration of CAPD 31 mo (range 3–127). In addition
CA125 was measured 2 monthly at routine clinic visits. There was noThe ratio PRR/URR was 62%, as would be expected since phosphate
is dialysed less efficiently that urea. 49% of patients had a PRR of statistically significant correlation between CA125 and patient sex, age,
presence of diabetes, duration of CAPD, and peritoneal transportless than 35%, perhaps suggesting that in some patients phosphate
removal was inefficient. URR was associated with dialysis duration (P characteristics (D/Do glucose, D/P creatinine or ultrafiltration volume).
However CA125 was less in those who used $1 3 2.27% glucose bags, 0.0001), blood volume processed (P , 0.0005) and dialyser surface
area (P 5 0.0018). However PRR was associated with none of the (14 65 IU/ml (mean 6 sd)) compared to those only using 1.36/1.5%
glucose (17.5 6 8.6, P , 0.05). CA125 was greatest in those with aabove. We also examined 8 patients who had measurements of PRR
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history of .1 episode of CAPD peritonitis (25.9 6 6.8), compared to catheter removal. CA125 does significantly increase in dialysate efflu-
ent during episodes of intraperitoneal inflammation in CAPD patients,those with 1 (20.5 6 6) and those with no history of peritonitis (14.2 6
5), P , 0.05. CA125 increased during 21 episodes of peritonitis from and failure to decrease may be predictive of those who fail to respond
to treatment. CA125 was greater in those with previous episodes of21 6 8.9 to 67 6 43.7 (at presentation), P , 0.05, and decreased to
36.6 6 21 (72 hrs) and to 21.9 6 9.6 (2 months) in those patients who peritonitis. However, CA125 did not predict peritoneal transport char-
acteristics, and did not significantly change with duration of CAPDwere successfully treated, whereas CA125 did not fall in 6 patients
who failed to respond (60 6 18 at 72 hrs) and subsequently required treatment.
